var title_f11_26_11680="MAC short-axis";
var content_f11_26_11680=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mitral annular calcification, parasternal short-axis view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 275px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Parasternal short axis view of the left ventricle showing MAC along the posterior aspect of the mitral annulus.",
"    <div class=\"footnotes\">",
"     MV: mitral valve; MAC: mitral annular calcification",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rosario V. Freeman, MD, MS",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11680=[""].join("\n");
var outline_f11_26_11680=null;
var title_f11_26_11681="PEEP and pulmonary hemodynamics";
var content_f11_26_11681=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62645&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62645&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Effect of positive end-expiratory pressure (PEEP) on pulmonary hemodynamics",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pressure tracings from the same patient recorded at different levels of positive end-expiratory pressure (PEEP). The top panel shows 0 PEEP, the middle panel PEEP = 15 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O, and the bottom panel PEEP = 20 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O. Pulmonary artery pressure (P",
"    <sub>",
"     pa",
"    </sub>",
"    ) is shown at the left of the tracing. The right side of the tracing shows wedge (pulmonary artery occlusion) pressure (P",
"    <sub>",
"     paO",
"    </sub>",
"    ). The red bars indicate the degree of respiratory (or respirophasic) variation exhibited at each level of PEEP in pulmonary artery pressure and wedge pressure. The ratio of respiratory variation in pulmonary artery pressure divided by respiratory variation in the wedge pressure was close to 1 when PEEP = 0 or 15 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O PEEP. This increased to 2.3 at a level of 20 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O PEEP. This suggests a shift from West zone three to a non-zone three condition, where airway pressure has exceeded intravascular pressure at the balloon occluded pulmonary artery catheter tip. The end-expiratory wedge pressure value during PEEP = 20 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O is markedly higher than during PEEP = 15 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O (18 versus 10 mmHg), a change that cannot solely be explained by the increase in PEEP.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Teboul JL, Besbes M, Andrivet P, et al. J Crit Care 1992; 7:22.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11681=[""].join("\n");
var outline_f11_26_11681=null;
var title_f11_26_11682="Penetrating ear foreign body";
var content_f11_26_11682=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86325&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86325&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 494px\">",
"   <div class=\"ttl\">",
"    Tympanic membrane perforation from a penetrating foreign body of the external auditory canal",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 474px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows a postero-superior perforation (arrow) of the tympanic membrane of the right ear caused by a pencil point. Injury in this location can cause permanent hearing loss.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11682=[""].join("\n");
var outline_f11_26_11682=null;
var title_f11_26_11683="TGDC excision";
var content_f11_26_11683=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F64198&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F64198&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 542px\">",
"   <div class=\"ttl\">",
"    Excision of thyroglossal duct cyst and tract",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 522px; height: 331px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The standard operation for thyroglossal duct cyst is to resect the cyst in continuity witih the midportion of the hyoid bone and a core of tissue from the hyoid upwards toward the foramen cecum, an operation known as the Sistrunk procedure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11683=[""].join("\n");
var outline_f11_26_11683=null;
var title_f11_26_11684="Patient information: Lactose intolerance (The Basics)";
var content_f11_26_11684=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16172\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?32/38/33388\">",
"         Lactose content of different foods",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?9/5/9299\">",
"         Patient information: Diarrhea in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/34/34338\">",
"         Patient information: Diarrhea in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/27/35250\">",
"         Patient information: Food allergy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/31/22002\">",
"         Patient information: Gas and bloating (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/34/31265\">",
"         Patient information: Irritable bowel syndrome (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/24/25986\">",
"         Patient information: Stomach ache and stomach upset (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?35/29/36308\">",
"         Patient information: Acute diarrhea in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/1/27\">",
"         Patient information: Acute diarrhea in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/47/29429\">",
"         Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/14/6371\">",
"         Patient information: Gas and bloating (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/53/3926\">",
"         Patient information: Irritable bowel syndrome (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?5/24/5506\">",
"         Patient information: Upset stomach (functional dyspepsia) in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Lactose intolerance (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/lactose-intolerance-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H13162429\">",
"      <span class=\"h1\">",
"       What is lactose intolerance?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Lactose intolerance is a condition that makes it hard for your body to digest milk and foods made with milk (called dairy products). If you have lactose intolerance and you eat dairy products, you can get diarrhea, belly pain, and gas.",
"     </p>",
"     <p>",
"      Lactose intolerance can affect anyone. But it is most common among Native American, Asian, and black people.",
"     </p>",
"     <p>",
"      In people who do not have lactose intolerance, the body makes a protein called an &ldquo;enzyme&rdquo; that breaks down lactose, the main form of sugar found in milk. In people who do have lactose intolerance, the body either does not make enough of the enzyme, or the enzyme does not work as well as it should. Also, some infections, such as you might get with food poisoning, can damage the enzyme. But if that happens, the problem usually goes away within a few weeks. Luckily, people with lactose intolerance can take an enzyme supplement to help with their problem.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13162436\">",
"      <span class=\"h1\">",
"       What are the symptoms of lactose intolerance?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms happen only after you eat dairy foods. They can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Cramps or belly pain (usually around or below the belly button)",
"       </li>",
"       <li>",
"        Bloating (feeling like your belly is full of air)",
"       </li>",
"       <li>",
"        Gas",
"       </li>",
"       <li>",
"        Diarrhea (often it is bulky, foamy, and watery) &nbsp;",
"       </li>",
"       <li>",
"        Vomiting (this happens mostly in teens)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13162443\">",
"      <span class=\"h1\">",
"       Is there a test for lactose intolerance?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. But a test is not always needed. If your doctor or nurse suspects you have lactose intolerance, he or she might start by treating you for lactose intolerance. If you get better, you probably won&rsquo;t need any more tests.",
"     </p>",
"     <p>",
"      If you do need tests, there are 2 ways to test for lactose intolerance. One is a breathing test, and one is a blood test. The breathing test is more common.",
"     </p>",
"     <p>",
"      Your doctor or nurse will tell you how to prepare for your test. You will not be able to eat or drink anything for several hours before the test. Plus, you might have to change your medicines or stop smoking for a while before the test.",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Lactose hydrogen breath test",
"        </strong>",
"        &ndash; For this test, you drink a liquid that has lactose in it. Then you breathe into a special machine every 30 minutes. The machine measures how much hydrogen you breathe out. People who have lactose intolerance breathe out more hydrogen than normal. &nbsp;",
"       </li>",
"       <li>",
"        <strong>",
"         Lactose tolerance test",
"        </strong>",
"        &ndash; For this test, you drink a liquid that has lactose in it. The doctor or nurse will take blood samples from you when the test starts, and again 1 and 2 hours later. If your blood has low levels of sugar after you drink the lactose, it means you probably have lactose intolerance.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13162450\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you think you might have lactose intolerance, tell your doctor or nurse. He or she can ask you questions to make sure that there are no other problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13162457\">",
"      <span class=\"h1\">",
"       How is lactose intolerance treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment differs depending on how severe the problem is. But in general, treatment can include: &nbsp;",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Eating less dairy food",
"       </li>",
"       <li>",
"        Finding non-dairy sources of nutrients (such as calcium and vitamin D) and protein",
"       </li>",
"       <li>",
"        Taking an enzyme supplement that will help you break down dairy foods &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13162464\">",
"      <span class=\"h1\">",
"       How do I reduce the amount of dairy foods I eat?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can start by avoiding or cutting down on foods you know contain dairy. Dairy foods include milk, cream, ice cream, yogurt, cheese, and butter. This table shows how much lactose is in some common dairy foods (",
"      <a class=\"graphic graphic_table graphicRef55938 \" href=\"UTD.htm?32/38/33388\">",
"       table 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      Your doctor or nurse might suggest that you talk to a nutritionist to learn which foods have lactose. The nutritionist can also make sure that you get enough calcium and vitamin D in your diet.",
"     </p>",
"     <p>",
"      If you are really sensitive to dairy foods or lactose, you will also need to read the labels on everything you eat. Milk or lactose is sometimes added to foods you might not suspect, such as cereal, instant soups, and salad dressings. Check the ingredient list of foods for anything that might suggest lactose. Look for these words:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Milk, &ldquo;milk byproducts,&rdquo; &ldquo;dry milk powder,&rdquo; and &ldquo;dry milk solids&rdquo;",
"       </li>",
"       <li>",
"        Lactose",
"       </li>",
"       <li>",
"        Whey (whey is milk that has gone sour)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Also, keep in mind that some medicines are made with lactose. Most people who are lactose intolerant can handle the very small amount in medicines. But if you are very sensitive, mention it to your pharmacist.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13162471\">",
"      <span class=\"h1\">",
"       Which enzyme supplement should I use?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are many enzyme supplements to choose from, including Lactaid (tablets or liquid), Lactrase, LactAce, Dairy Ease, and Lactrol. You should take the supplement right before you start eating. If you forget, you can take it during the meal, but it might not work as well.",
"     </p>",
"     <p>",
"      The important thing to know is that each product works a bit differently for each person. Plus, none of them can break down every last bit of lactose, so some people still have symptoms even with an enzyme supplement.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13162478\">",
"      <span class=\"h1\">",
"       Should I take calcium or vitamin D supplements?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on whether you completely avoid dairy foods. If you do, your doctor or nurse might recommend calcium supplements. He or she might also check your vitamin D levels to decide whether you should take supplements.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13162485\">",
"      <span class=\"h1\">",
"       Is lactose intolerance basically a food allergy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. There are people who are allergic to milk and dairy foods. But the symptoms of a dairy allergy are often different than those of lactose intolerance. In the case of an allergy, the body reacts to the protein in milk, rather than to the sugar. Plus, allergies involve the body&rsquo;s infection-fighting system, called the immune system. Lactose intolerance does not.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13162627\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/24/25986?source=see_link\">",
"       Patient information: Stomach ache and stomach upset (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/31/22002?source=see_link\">",
"       Patient information: Gas and bloating (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/34/34338?source=see_link\">",
"       Patient information: Diarrhea in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/5/9299?source=see_link\">",
"       Patient information: Diarrhea in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/27/35250?source=see_link\">",
"       Patient information: Food allergy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/34/31265?source=see_link\">",
"       Patient information: Irritable bowel syndrome (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/14/6371?source=see_link\">",
"       Patient information: Gas and bloating (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?5/24/5506?source=see_link\">",
"       Patient information: Upset stomach (functional dyspepsia) in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/29/36308?source=see_link\">",
"       Patient information: Acute diarrhea in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=see_link\">",
"       Patient information: Acute diarrhea in children (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/47/29429?source=see_link\">",
"       Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?3/53/3926?source=see_link\">",
"       Patient information: Irritable bowel syndrome (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?11/26/11684?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16172 Version 4.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-EF0CD76C64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11684=[""].join("\n");
var outline_f11_26_11684=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162429\">",
"      What is lactose intolerance?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162436\">",
"      What are the symptoms of lactose intolerance?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162443\">",
"      Is there a test for lactose intolerance?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162450\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162457\">",
"      How is lactose intolerance treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162464\">",
"      How do I reduce the amount of dairy foods I eat?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162471\">",
"      Which enzyme supplement should I use?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162478\">",
"      Should I take calcium or vitamin D supplements?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162485\">",
"      Is lactose intolerance basically a food allergy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13162627\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16172\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/38/33388\">",
"      Lactose content of different foods",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/29/36308?source=related_link\">",
"      Patient information: Acute diarrhea in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=related_link\">",
"      Patient information: Acute diarrhea in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/5/9299?source=related_link\">",
"      Patient information: Diarrhea in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/34/34338?source=related_link\">",
"      Patient information: Diarrhea in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/27/35250?source=related_link\">",
"      Patient information: Food allergy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/47/29429?source=related_link\">",
"      Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/14/6371?source=related_link\">",
"      Patient information: Gas and bloating (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/31/22002?source=related_link\">",
"      Patient information: Gas and bloating (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/53/3926?source=related_link\">",
"      Patient information: Irritable bowel syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/34/31265?source=related_link\">",
"      Patient information: Irritable bowel syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/24/25986?source=related_link\">",
"      Patient information: Stomach ache and stomach upset (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/24/5506?source=related_link\">",
"      Patient information: Upset stomach (functional dyspepsia) in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_26_11685="Ampicillin: Patient drug information";
var content_f11_26_11685=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ampicillin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     see \"Ampicillin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     see \"Ampicillin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F134956\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ampicillin for Injection;",
"     </li>",
"     <li>",
"      Apo-Ampi&reg;;",
"     </li>",
"     <li>",
"      Novo-Ampicillin;",
"     </li>",
"     <li>",
"      Nu-Ampi",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701514",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ampicillin, any penicillin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store capsules at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699472",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (suspension) in a refrigerator or at room temperature. Throw away any part not used after 2 weeks if refrigerated. Throw away any part not used after 1 week if stored at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to store the shot closely. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018274\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10902 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-F8E45503D2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11685=[""].join("\n");
var outline_f11_26_11685=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134956\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018265\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018264\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018269\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018270\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018272\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018267\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018268\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018273\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018274\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=related_link\">",
"      Ampicillin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=related_link\">",
"      Ampicillin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_26_11686="Formoterol: Pediatric drug information";
var content_f11_26_11686=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Formoterol: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?13/52/14151?source=see_link\">",
"    see \"Formoterol: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?22/56/23430?source=see_link\">",
"    see \"Formoterol: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F174082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Foradil&reg; Aerolizer&reg;;",
"     </li>",
"     <li>",
"      Perforomist&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F174083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Foradil&reg;;",
"     </li>",
"     <li>",
"      Oxeze&reg; Turbuhaler&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1058850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Adrenergic Agonist Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiasthmatic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Beta",
"       <sub>",
"        2",
"       </sub>",
"       -Adrenergic Agonist",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Bronchodilator",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Sympathomimetic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1058843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/52/14151?source=see_link\">",
"      see \"Formoterol: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Asthma, maintenance treatment:",
"     </b>",
"     Children &ge;5 years, Adolescents, and Adults: Inhalation: Foradil&reg; Aerolizer&trade;: 12 mcg (contents of 1 capsule aerosolized) twice daily, 12 hours apart; maximum daily dose: 24 mcg;",
"     <b>",
"      Note:",
"     </b>",
"     For long-term asthma control, long-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists should be used in combination with inhaled corticosteroids and",
"     <b>",
"      not",
"     </b>",
"     as monotherapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Exercise-induced asthma, prevention:",
"     </b>",
"     Children &ge;5 years, Adolescents, and Adults: Inhalation: Foradil&reg; Aerolizer&trade;: 12 mcg (contents of 1 capsule aerosolized) 15 minutes prior to exercise; additional doses should not be used for 12 hours; maximum daily dose: 24 mcg; patients who are using formoterol twice daily should",
"     <b>",
"      not",
"     </b>",
"     use an additional formoterol dose prior to exercise; if twice daily use is not effective during exercise, consider other appropriate therapy;",
"     <b>",
"      Note:",
"     </b>",
"     Because long-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists (LABAs) may disguise poorly-controlled persistent asthma, frequent or chronic use of LABAs for exercise-induced bronchospasm is discouraged by the NAEPP Asthma Guidelines (NAEPP, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      COPD, maintenance treatment:",
"     </b>",
"     Adults: Inhalation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Foradil&reg; Aerolizer&trade;: 12 mcg (contents of 1 capsule aerosolized) twice daily, 12 hours apart; maximum daily dose: 24 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Perforomist&trade;: 20 mcg (2 mL) twice daily by nebulization; maximum daily dose: 40 mcg",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F174059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder, for oral inhalation, as fumarate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Foradil&reg; Aerolizer&reg;: 12 mcg/capsule (12s, 60s) [contains lactose 25 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, for nebulization, as fumarate dihydrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Perforomist&reg;: 20 mcg/2 mL (60s)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F174045\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1058854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Foradil&reg; Aerolizer&trade;: Remove capsule from foil blister immediately before use. The contents of a capsule are aerosolized via a device called an Aerolizer&trade;. Place the capsule into the Aerolizer&trade;. The capsule is pierced by pressing and releasing the buttons on the side of the Aerolizer&trade;. The formoterol formulation is dispersed into the air stream when the patient inhales rapidly and deeply through the mouthpiece. The patient should not exhale into the device. May not be used with spacer device.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perforomist&trade;: Remove unit-dose vial from foil pouch immediately before use. Solution does not require dilution prior to administration; do not mix other medications with Perforomist&trade; solution. Place contents of vial into the reservoir of a standard jet nebulizer connected to an air compressor; nebulize until all of the medication has been inhaled. Discard any unused medication immediately. Not for oral ingestion.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1058846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Foradil&reg; Aerolizer&trade;: Prior to dispensing, store in refrigerator at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); after dispensing, store at controlled room temperature at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); protect from heat and moisture. Capsules should always be stored in the blister pack and only removed immediately before use. Use within 4 months of purchase date or product expiration date, whichever comes first.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perforomist&trade;: Prior to dispensing, store in refrigerator  at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); after dispensing, store at controlled room temperature at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F) for up to 3 months. Protect from heat. Unit-dose vials should always be stored in the foil pouch and only removed immediately before use.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1058853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Foradil&reg; Aerolizer&trade;: Concomitant therapy with inhaled corticosteroids for maintenance treatment of asthma and prevention of bronchospasm in patients with reversible obstructive airway disease, including patients with nocturnal symptoms (FDA approved in &ge;5 years and adults); prevention of exercise-induced bronchospasm as concomitant therapy in patients with persistent asthma and as monotherapy in those without persistent asthma (FDA approved in &ge;5 years and adults);",
"     <b>",
"      NOT",
"     </b>",
"     indicated for the relief of acute bronchospasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Foradil&reg; Aerolizer&trade;, Perforomist&trade;: Maintenance treatment of bronchoconstriction in COPD (FDA approved in adults);",
"     <b>",
"      NOT",
"     </b>",
"     indicated for the relief of acute bronchospasm",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F174129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Foradil&reg; may be confused with Toradol&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Foradil&reg; capsules for inhalation are for administration via Aerolizer&reg; inhaler and are",
"       <b>",
"        not",
"       </b>",
"       for oral use.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Foradil [U.S., Canada, and multiple international markets] may be confused with Theradol brand name for tramadol [Netherlands]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F174127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Chest pain, palpitation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety, dizziness, dysphonia, fever, headache, insomnia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, dyspepsia, gastroenteritis, nausea, vomiting,  xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Muscle cramps, tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Asthma exacerbation, bronchitis, dyspnea, infection, pharyngitis, sinusitis, tonsillitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Viral infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Acute asthma deterioration, anaphylactic reactions (severe hypotension/angioedema), agitation, angina, arrhythmia, atrial fibrillation, bronchospasm (paradoxical), cough, fatigue, hyperglycemia, hypertension, hypokalemia, glucose intolerance, malaise, metabolic acidosis, nervousness, QTc prolongation, tachycardia, ventricular extrasystoles",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1058858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to formoterol, adrenergic amines, or any component; monotherapy in the treatment of asthma (ie, use without a concomitant long-term asthma control medication, such as an inhaled corticosteroid); treatment of status asthmaticus or other acute episodes of asthma or COPD",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1058842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with cardiovascular disorders (especially coronary insufficiency, arrhythmias, hypertension, heart failure), although uncommon at recommended doses, beta-agonists may cause elevation in BP and HR and result in CNS stimulation and excitation. Caution should also be used in patients with thyrotoxicosis, seizure disorders, or conditions that are unusually sensitive to sympathomimetic amines. Transient hypokalemia from intracellular shunting may occur and produce adverse cardiovascular effects. Use with caution in patients with diabetes mellitus (DM); beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists can increase serum glucose aggravating pre-existing DM and ketoacidosis. Use caution in patients with hepatic impairment. Immediate hypersensitivity reactions (urticaria, angioedema, rash, bronchospasm) have been reported. Foradil&reg; aerolizer contains lactose; very rare anaphylactic reactions have been reported in patients with severe milk protein allergy.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1058841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Long-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -adrenergic agents (LABAs), including  formoterol, increase the risk of  asthma-related deaths",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Formoterol should only be prescribed in patients not adequately controlled on long-term asthma-controller medications (ie, inhaled corticosteroid) or  whose disease requires initiation of two maintenance therapies; monotherapy with a LABA is contraindicated in the treatment of asthma. In a large clinical trial, LABA (salmeterol) use was associated with an increase in asthma-related deaths compared to placebo (when added to usual asthma therapy); risk is considered a class effect among all LABAs. Data are not available to determine if the addition of an inhaled corticosteroid lessens this increased risk of death associated with LABA use or if LABA use also increases the risk of death in patients with COPD. Assess patients at regular intervals once asthma control is maintained on combination therapy to determine if step down therapy is appropriate (without loss of asthma control), and if the patient can be maintained on an inhaled corticosteroid alone. LABAs are not appropriate in patients whose asthma is adequately controlled on low- or medium-dose inhaled corticosteroids. LABAs may increase the risk of asthma-related hospitalization in pediatric and adolescent patients",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . When addition of a LABA is clinically indicated in patients &lt;18 years of age, a combination product containing a LABA and an inhaled corticosteroid is preferred to ensure compliance.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Formoterol should not be used to relieve acute asthmatic or COPD symptoms or rapidly deteriorating or potentially life-threatening episodes of asthma or COPD; acute episodes should be treated with short-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists. Routine use of inhaled, short-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists should be discontinued prior to initiation of formoterol. Corticosteroids should not be stopped or reduced when formeterol is initiated. Formoterol should not be used more frequently than recommended (twice daily), at higher doses, or with any additional long-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -adrenergic agonist; adverse cardiovascular effects (possibly fatal) have been reported with excessive beta",
"     <sub>",
"      2",
"     </sub>",
"     -adrenergic overstimulation. Use with strong CYP3A4 inhibitors (eg, ketoconazole, ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin) is not recommended due to potential for an increased risk of cardiovascular events. Paroxysmal bronchospasm (which can be fatal) has been reported with formoterol and other inhaled beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists; if this occurs, discontinue treatment; most commonly occurs with first use of a new canister or vial. Symptoms of laryngeal spasm, irritation, or swelling, such as stridor and choking, have been reported; if  occurs, discontinue treatment.  Because LABAs may disguise poorly controlled persistent asthma, frequent or chronic use of LABAs for exercise-induced bronchospasm is discouraged by the NAEPP Asthma Guidelines (NAEPP, 2007).  Foradil&reg; capsules should",
"     <b>",
"      only",
"     </b>",
"     be used with the Aerolizer&trade; inhaler and should",
"     <b>",
"      not",
"     </b>",
"     be taken orally.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F174116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C9 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F174053\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Blockers: May diminish the therapeutic effect of Beta2-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the tachycardic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atosiban: Beta2-Agonists may enhance the adverse/toxic effect of Atosiban. Specifically, there may be an increased risk for pulmonary edema and/or dyspnea.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers (Beta1 Selective): May diminish the bronchodilatory effect of Beta2-Agonists. Of particular concern with nonselective beta-blockers or higher doses of the beta1 selective beta-blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers (Nonselective): May diminish the bronchodilatory effect of Beta2-Agonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: May diminish the therapeutic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Caffeine: May enhance the adverse/toxic effect of Formoterol. Caffeine may enhance the hypokalemic effect of Formoterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Inhalational Anesthetics: May enhance the arrhythmogenic effect of Formoterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Beta2-Agonists may enhance the hypokalemic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the adverse/toxic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: May enhance the adverse/toxic effect of Formoterol. Theophylline Derivatives may enhance the hypokalemic effect of Formoterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Beta2-Agonists may enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May enhance the adverse/toxic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F174055\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F174068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     When given orally to rats throughout organogenesis, formoterol caused delayed ossification and decreased fetal weight, but no malformations. There were no adverse events when given to pregnant rats in late pregnancy. Doses used were &ge;70 times the recommended daily inhalation dose in humans. There are no adequate and well-controlled studies in pregnant women. Use only if benefit outweighs risk to the fetus. Beta-agonists interfere with uterine contractility so use during labor only if benefit outweighs risk to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1058849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pulmonary function tests, vital signs, CNS stimulation, serum glucose, serum potassium",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1058840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Formoterol is a long-acting selective beta",
"     <sub>",
"      2",
"     </sub>",
"     -adrenergic receptor agonist. It relaxes bronchial smooth muscle by selective action on beta",
"     <sub>",
"      2",
"     </sub>",
"     -receptors with little effect on heart rate",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1058856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Powder for oral inhalation: 1-3 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Peak effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Powder for oral inhalation: 80% of peak effect within 15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Solution for nebulization: Median: 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Improvement in FEV",
"     <sub>",
"      1",
"     </sub>",
"     observed for 12 hours in most patients",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1058857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapidly into plasma",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 61% to 64%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensive via glucuronidation and o-demethylation; CYP2D6, CYP2C8/9, CYP2C19, CYP2A6 involved in O-demethylation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Powder for oral inhalation: ~10-14 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Solution for nebulization: ~7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Inhalation: 5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 5-12 years: 7% to 9% eliminated in urine as direct glucuronide metabolites, 6% as unchanged drug",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: 15% to 18% eliminated in urine as direct glucuronide metabolites, 2% to 10% as unchanged drug",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1058848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/56/23430?source=see_link\">",
"      see \"Formoterol: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not use to treat acute symptoms; do not exceed the prescribed dose of formoterol; do not stop using inhaled or oral corticosteroids without medical advice even if feeling better; may cause dry mouth; the capsule is not to be taken by mouth",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1058859\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     When formoterol is initiated in patients previously receiving a short-acting beta agonist, instruct the patient to discontinue the regular use of the short-acting beta agonist and to utilize the shorter-acting agent for symptomatic or acute episodes only.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bisgaard H, &ldquo;Long-acting Beta",
"      <sub>",
"       2",
"      </sub>",
"      -Agonists in Management of Childhood Asthma: A Critical Review of the Literature,&rdquo;",
"      <i>",
"       Pediatr Pulmonol",
"      </i>",
"      , 2000, 29(3):221-34",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/26/11686/abstract-text/10686044/pubmed\" id=\"10686044\" target=\"_blank\">",
"        10686044",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Asthma Education and Prevention Program (NAEPP), &ldquo;Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma,&rdquo; Clinical Practice Guidelines, National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 08-4051, prepublication 2007. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm",
"      </a>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13324 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-1D88657B2A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11686=[""].join("\n");
var outline_f11_26_11686=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708810\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174082\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174083\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058850\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058843\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174059\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174045\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874607\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058854\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058846\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058853\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174129\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174127\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058858\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058842\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058841\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174116\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174053\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174055\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174068\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058849\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058840\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058856\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058857\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058848\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058859\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13324\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13324|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/52/14151?source=related_link\">",
"      Formoterol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/56/23430?source=related_link\">",
"      Formoterol: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_26_11687="Bone disease in diabetes mellitus";
var content_f11_26_11687=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bone disease in diabetes mellitus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/26/11687/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/26/11687/contributors\">",
"     Lesley D Hordon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/26/11687/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/26/11687/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/26/11687/contributors\">",
"     Marc K Drezner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/26/11687/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/26/11687/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/26/11687/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association between diabetes mellitus and osteoporosis remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/1\">",
"     1",
"    </a>",
"    ]. Although the metabolic abnormalities of diabetes potentially affect bone metabolism, structure, and mineral density, the extent of their contribution to the increase in fracture risk noted in individuals with type 1 and type 2 diabetes is still debated. In addition to changes in bone metabolism, there are several other factors that may be important:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The onset of diabetes in adolescence may result in a decreased peak bone mass.",
"     </li>",
"     <li>",
"      The degree of bone loss differs between type 1 and type 2 diabetes. In some studies, type 2 diabetes has been associated with an increase in bone mineral density [",
"      <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bone fragility, particularly in type 2 diabetes, may contribute to fracture risk independent of bone mineral density, and BMD may not reflect fracture risk in some individuals.",
"     </li>",
"     <li>",
"      Bone metabolism may be affected by the late complications of diabetes (eg, renal failure).",
"     </li>",
"     <li>",
"      The risk of fracture may be increased by falling secondary to visual impairment, cerebrovascular disease, or neuropathy.",
"     </li>",
"     <li>",
"      Localized bone loss related to diabetic neuropathy may increase the risk of fracture at the foot and ankle.",
"     </li>",
"     <li>",
"      Specific treatments may influence fracture rates.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the effects of type 1 and type 2 diabetes on bone (",
"    <a class=\"graphic graphic_table graphicRef51539 \" href=\"UTD.htm?3/21/3421\">",
"     table 1",
"    </a>",
"    ). The musculoskeletal complications of diabetes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22358?source=see_link\">",
"     \"Musculoskeletal complications in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BONE METABOLISM IN DIABETES MELLITUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in bone histomorphometry in type 1 diabetes have generally [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/1\">",
"     1",
"    </a>",
"    ], but not always [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/3\">",
"     3",
"    </a>",
"    ], shown a low turnover of bone with reduction in bone formation and, to a lesser degree, bone resorption. The decrease in bone formation is manifested by reduced serum concentrations of osteocalcin, a marker of osteoblastic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In comparison, resorption markers (such as serum tartrate resistant acid phosphatase and urinary hydroxyproline) are increased in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/5,6\">",
"     5,6",
"    </a>",
"    ], perhaps related to alterations in renal function [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/33/42519?source=see_link\">",
"     \"Bone physiology and biochemical markers of bone turnover\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similar changes have been noted in diabetic patients who progress to end-stage renal disease. Compared with normal subjects, patients with diabetes are more likely to have adynamic bone disease (including that associated with aluminum deposition) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/7,8\">",
"     7,8",
"    </a>",
"    ], whereas hyperparathyroid bone disease is infrequent, occurring in less than 10 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/50/18218?source=see_link&amp;anchor=H13#H13\">",
"     \"Pathogenesis of renal osteodystrophy\", section on 'Adynamic bone disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanism for the reduced bone turnover in type 1 diabetes is likely multifactorial. Studies in uremic rats suggest that lack of insulin may diminish bone turnover [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/11\">",
"     11",
"    </a>",
"    ]. However, insulin deficiency may also be important earlier, since decreased bone formation can be demonstrated in type 1 diabetics before the onset of clinical renal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/1,7,9\">",
"     1,7,9",
"    </a>",
"    ]. The anabolic effects of insulin may be mediated through the IGF-1 pathway, and in type 1 diabetes low levels of insulin and insulin-like growth factor 1 (IGF-1) may impair osteoblast function [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/12\">",
"     12",
"    </a>",
"    ]. In contrast, obesity induced insulin resistance in type 2 diabetes leads to increased levels of insulin and IGF-1, with a possible anabolic effect on bone (",
"    <a class=\"graphic graphic_table graphicRef51539 \" href=\"UTD.htm?3/21/3421\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The accumulation of advanced glycation end products (AGE) in collagen as a result of hyperglycemia also may contribute to reduced bone formation. Low bone turnover, with a reduction in unmineralized bone matrix, and increased collagen glycosylation may contribute to increased fragility of diabetic bone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/1,13\">",
"     1,13",
"    </a>",
"    ]. The increase in bone fragility may not be predicted by measurement of bone density [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another factor that can affect bone metabolism in diabetes is hypercalciuria [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/3,15\">",
"     3,15",
"    </a>",
"    ]. The mechanism by which this occurs is not clear but it can be ameliorated with insulin [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/15\">",
"     15",
"    </a>",
"    ]. Both the loss of bone mineral and functional hypoparathyroidism may play a contributory role [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/3,16\">",
"     3,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     BONE DENSITY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Type 1 diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children and adolescents with type 1 diabetes have reduced bone mineral density (BMD) at the forearm [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/17,18\">",
"     17,18",
"    </a>",
"    ], which appears constant with time [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/17\">",
"     17",
"    </a>",
"    ]. It is less clear whether this deficit is present at the lumbar spine. Variable findings have been reported ranging from reductions in trabecular but not cortical BMD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/19\">",
"     19",
"    </a>",
"    ] to no deficit reported when BMD is corrected for weight [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/20\">",
"     20",
"    </a>",
"    ]. It is hypothesized that any defect in BMD is due to a failure to acquire endosteal bone during growth (",
"    <a class=\"graphic graphic_table graphicRef51539 \" href=\"UTD.htm?3/21/3421\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In adults with type 1 diabetes, lumbar BMD is usually normal [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/21-23\">",
"     21-23",
"    </a>",
"    ], while femoral BMD is reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/2,21-24\">",
"     2,21-24",
"    </a>",
"    ]. In most studies there was no relationship between BMD and the duration of diabetes or glycemic control [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/17,18,20-22,25\">",
"     17,18,20-22,25",
"    </a>",
"    ]. However, these findings have not been uniformly found [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/5,19,24,25\">",
"     5,19,24,25",
"    </a>",
"    ]. One study of premenopausal women, for example, found increased lumbar BMD and normal femoral BMD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/25\">",
"     25",
"    </a>",
"    ]. In another study, lumbar BMD was low; the study included a high proportion of patients with retinopathy and neuropathy, suggesting that microvascular disease can influence BMD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/24\">",
"     24",
"    </a>",
"    ]. A link between neuropathy and low femoral neck BMD has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Type 2 diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of studies in type 2 diabetes have found that BMD is normal or increased at the lumbar spine [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/26-29\">",
"     26-29",
"    </a>",
"    ], femoral neck [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/2,26,28-30\">",
"     2,26,28-30",
"    </a>",
"    ], and mid and distal radius [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/28\">",
"     28",
"    </a>",
"    ]. These findings applied to both women and men [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. As expected, BMD correlated with body mass index [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/27\">",
"     27",
"    </a>",
"    ]. However, in those studies that corrected for body mass index, increased BMD was independent of obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/26,28,29\">",
"     26,28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study of older well-functioning patients with type 2 diabetes showed higher hip, total body, and volumetric spine BMD in black and white men and women compared with their appropriate controls, although a lower spine bone volume was found in diabetes subjects, which may possibly decrease bone strength [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A longitudinal 12-year study of 109 patients with both type 1 and type 2 diabetes reported two major findings [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radial BMD was lower than in normal subjects in both groups at baseline.",
"     </li>",
"     <li>",
"      The rate of decline in radial BMD over time was similar to that in normal subjects in type 1 diabetes and less than that in normal subjects in type 2 diabetes, such that the original deficit was reversed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The authors proposed that impaired osteoblast recruitment or function was responsible for the original reduction in BMD and that low bone turnover diminished age-related bone loss in older patients with type 2 diabetes. One limitation of these findings is that BMD could only be measured in survivors, which comprised just over one-half of the original study population.",
"   </p>",
"   <p>",
"    One group of individuals with type 2 diabetes who appear to be at risk for an increased rate of bone loss is women treated with thiazolidinediones. Additional studies are warranted to further explore this area. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21290?source=see_link&amp;anchor=H18#H18\">",
"     \"Thiazolidinediones in the treatment of diabetes mellitus\", section on 'Safety'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     FRACTURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although some studies have not found a relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/29,32,33\">",
"     29,32,33",
"    </a>",
"    ], the majority have demonstrated an increased risk of fracture in patients with diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/34-49\">",
"     34-49",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Women's Health Initiative Observational Study, a prospective cohort study of 93,676 postmenopausal women, women with type 2 diabetes (n = 5285) had an increased risk of fracture after seven years of follow-up compared with women without diabetes (adjusted relative risk [RR] 1.20, 95% CI 1.11-1.30) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A systematic review and a meta-analysis of diabetes and fracture showed similar increases in risk of hip fracture in patients with either type 1 diabetes (RRs 6.3 and 6.9, respectively) or type 2 diabetes (RRs 1.7 and 1.4, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/43,50\">",
"       43,50",
"      </a>",
"      ]. Results from the meta-analysis also showed that BMD was increased at the spine and hip in type 2 diabetics but decreased at both sites in type 1 diabetics [",
"      <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/43\">",
"       43",
"      </a>",
"      ]. Fracture risk was higher and BMD lower in those with diabetic complications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In population-based studies, an association between risk of fractures (proximal humerus, vertebral, and hip) and longer diabetes duration, diabetic retinopathy, advanced cortical cataract, neuropathy, and insulin treatment has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/41,47\">",
"     41,47",
"    </a>",
"    ]. In one study, the association between retinopathy and fracture risk remained significant after adjusting for visual acuity, suggesting that retinopathy may be acting as a proxy for severe diabetic microvascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/41\">",
"     41",
"    </a>",
"    ]. An increased risk of falling in older diabetic women also has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a retrospective study, an increased incidence of foot fractures, predominantly metatarsal, has also been described in diabetic athletes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/38\">",
"     38",
"    </a>",
"    ]. Fractures were more common in men and were associated with a long duration of disease. In addition, diabetic neuropathy has been associated with osteopenia in both hands and feet, metatarsal fractures, and a subsequent risk of osteopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The possibility that fracture risk is associated with disease duration and presence of long-term complications was also illustrated by a retrospective population-based cohort study of 82,000 adults with diabetes and over 236,000 matched non-diabetic controls [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/52\">",
"     52",
"    </a>",
"    ]. The risk of osteoporotic fractures (RR 1.15, 95% CI 1.09-1.22) and hip fractures (RR 1.40, 95% CI 1.28-1.53) was increased in adults with long-term diabetes, whereas fracture risk was decreased in newly diagnosed diabetes (RRs 0.91, 95% CI 0.86-0.95 and 0.83, 95% CI 0.75-0.92 for osteoporotic and hip fractures, respectively).",
"   </p>",
"   <p>",
"    Fracture risk may also be related to therapy. A Diabetes Outcome Progression Trial (ADOPT) reported a higher rate of fractures in newly diagnosed women with diabetes randomly assigned to receive four years of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2472?source=see_link\">",
"     rosiglitazone",
"    </a>",
"    , as opposed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/6/29800?source=see_link\">",
"     glyburide",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/35/43577?source=see_link\">",
"     \"Initial management of blood glucose in type 2 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21290?source=see_link&amp;anchor=H18#H18\">",
"     \"Thiazolidinediones in the treatment of diabetes mellitus\", section on 'Safety'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Taken together, the above data suggest that BMD is lower in patients with type 1 diabetes and normal or increased in patients with type 2 diabetes. However, fracture risk appears increased in both groups, possibly related to factors in addition to BMD, such as duration of diabetes, diabetic complications, bone quality, treatment, and risk of falling (",
"    <a class=\"graphic graphic_table graphicRef51539 \" href=\"UTD.htm?3/21/3421\">",
"     table 1",
"    </a>",
"    ). The clinical evaluation of fracture risk in patients with diabetes mellitus is the same as in patients without diabetes and includes assessment of BMD and clinical risk factors. A fracture risk assessment tool, such as the World Health Organization Fracture Risk Assessment Tool (FRAX), can be used to express the probability of fracture over a specified period of time. However, for a given BMD T-score or FRAX score, the risk of fracture may be higher in older adults with diabetes compared with those without diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. At present, the FRAX algorithm does not include diabetes as a risk factor. Fracture risk assessment, including a description of FRAX and the clinical applications of fracture risk assessment, is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/42/29354?source=see_link&amp;anchor=H2#H2\">",
"     \"Osteoporotic fracture risk assessment\", section on 'Assessment of fracture risk'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fracture healing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolonged fracture healing has been described in both type 1 and type 2 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. This occurred in patients with displaced fractures and those treated by open reduction, while healing time was normal in patients with nondisplaced fractures. Reduced bone turnover, as mentioned above, may account for the delay in healing [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PREVENTION AND TREATMENT OF OSTEOPOROSIS IN DIABETIC WOMEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;At present, there are few studies specifically addressing the prevention and treatment of osteoporosis in diabetic women. In a subgroup analysis of a larger study, the Fracture Intervention Trial, three years of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/10/24743?source=see_link\">",
"     alendronate",
"    </a>",
"    therapy resulted in similar improvements in bone density in postmenopausal women with (n = 297) or without diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The general recommendations regarding healthy lifestyle, exercise, calcium and vitamin D supplementation are applicable to postmenopausal women with diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11687/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. In the absence of studies specifically targeting osteoporosis in individuals with diabetes, treatment recommendations should follow other guidelines, such as for postmenopausal women and men. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=see_link\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31657?source=see_link\">",
"     \"Treatment of osteoporosis in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;DISH is a common degenerative enthesopathy affecting both the axial and appendicular skeleton that may occur with increased frequency in diabetics. The etiology of DISH is not known. Its possible relationship with diabetes and obesity and its occurrence in patients with acromegaly have led to the evaluation of the pathogenetic role of insulin, insulin-like growth factor, and growth hormone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/59/43960?source=see_link\">",
"     \"Diffuse idiopathic skeletal hyperostosis (DISH)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with diabetes typically have low bone turnover with reduction in bone formation and, to a lesser degree, bone resorption. The mechanism for the reduced bone turnover is likely multifactorial. In type 1 diabetes, low levels of insulin and insulin-like growth factor 1 (IGF-1) may impair osteoblast function. In both type 1 and type 2 diabetes, the accumulation of advanced glycation end products (AGE) in collagen as a result of hyperglycemia also may contribute to reduced bone formation (",
"      <a class=\"graphic graphic_table graphicRef51539 \" href=\"UTD.htm?3/21/3421\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Bone metabolism in diabetes mellitus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      BMD is lower in patients with type 1 diabetes and normal or increased in patients with type 2 diabetes. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Bone density'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fracture risk is increased in both groups, possibly related to factors in addition to BMD, such as duration of diabetes, diabetic complications, bone quality, treatment, and risk of falling (",
"      <a class=\"graphic graphic_table graphicRef51539 \" href=\"UTD.htm?3/21/3421\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Fracture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the absence of studies specifically targeting osteoporosis in individuals with diabetes, treatment recommendations should follow other guidelines, such as for postmenopausal women and men. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=see_link\">",
"       \"Overview of the management of osteoporosis in postmenopausal women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31657?source=see_link\">",
"       \"Treatment of osteoporosis in men\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/1\">",
"      Bouillon R. Diabetic bone disease. Calcif Tissue Int 1991; 49:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/2\">",
"      Tuominen JT, Impivaara O, Puukka P, R&ouml;nnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999; 22:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/3\">",
"      McNair P. Bone mineral metabolism in human type 1 (insulin dependent) diabetes mellitus. Dan Med Bull 1988; 35:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/4\">",
"      Pedrazzoni M, Ciotti G, Pioli G, et al. Osteocalcin levels in diabetic subjects. Calcif Tissue Int 1989; 45:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/5\">",
"      Olmos JM, P&eacute;rez-Castrill&oacute;n JL, Garc&iacute;a MT, et al. Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus. Bone Miner 1994; 26:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/6\">",
"      Selby PL, Shearing PA, Marshall SM. Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria. Diabet Med 1995; 12:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/7\">",
"      Andress DL, Kopp JB, Maloney NA, et al. Early deposition of aluminum in bone in diabetic patients on hemodialysis. N Engl J Med 1987; 316:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/8\">",
"      Pei Y, Hercz G, Greenwood C, et al. Renal osteodystrophy in diabetic patients. Kidney Int 1993; 44:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/9\">",
"      Vincenti F, Arnaud SB, Recker R, et al. Parathyroid and bone response of the diabetic patient to uremia. Kidney Int 1984; 25:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/10\">",
"      Vincenti F, Hattner R, Amend WJ Jr, et al. Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis. JAMA 1981; 245:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/11\">",
"      Jara A, Bover J, Felsenfeld AJ. Development of secondary hyperparathyroidism and bone disease in diabetic rats with renal failure. Kidney Int 1995; 47:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/12\">",
"      Epstein S, Leroith D. Diabetes and fragility fractures - a burgeoning epidemic? Bone 2008; 43:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/13\">",
"      Krakauer JC, McKenna MJ, Buderer NF, et al. Bone loss and bone turnover in diabetes. Diabetes 1995; 44:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/14\">",
"      Verhaeghe J, Suiker AM, Einhorn TA, et al. Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats. J Bone Miner Res 1994; 9:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/15\">",
"      Raskin P, Stevenson MR, Barilla DE, Pak CY. The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin Endocrinol (Oxf) 1978; 9:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/16\">",
"      Thalassinos NC, Hadjiyanni P, Tzanela M, et al. Calcium metabolism in diabetes mellitus: effect of improved blood glucose control. Diabet Med 1993; 10:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/17\">",
"      Hui SL, Epstein S, Johnston CC Jr. A prospective study of bone mass in patients with type I diabetes. J Clin Endocrinol Metab 1985; 60:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/18\">",
"      Weber G, Beccaria L, de'Angelis M, et al. Bone mass in young patients with type I diabetes. Bone Miner 1990; 8:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/19\">",
"      Lettgen B, Hauffa B, M&ouml;hlmann C, et al. Bone mineral density in children and adolescents with juvenile diabetes: selective measurement of bone mineral density of trabecular and cortical bone using peripheral quantitative computed tomography. Horm Res 1995; 43:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/20\">",
"      Ponder SW, McCormick DP, Fawcett HD, et al. Bone mineral density of the lumbar vertebrae in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr 1992; 120:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/21\">",
"      Compston JE, Smith EM, Matthews C, Schofield P. Whole body composition and regional bone mass in women with insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf) 1994; 41:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/22\">",
"      Forst T, Pf&uuml;tzner A, Kann P, et al. Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabet Med 1995; 12:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/23\">",
"      Mastrandrea LD, Wactawski-Wende J, Donahue RP, et al. Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care 2008; 31:1729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/24\">",
"      Kayath MJ, Dib SA, Vieira JG. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabetes Complications 1994; 8:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/25\">",
"      Gallacher SJ, Fenner JA, Fisher BM, et al. An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitus. Diabet Med 1993; 10:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/26\">",
"      Rishaug U, Birkeland KI, Falch JA, Vaaler S. Bone mass in non-insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 1995; 55:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/27\">",
"      Wakasugi M, Wakao R, Tawata M, et al. Bone mineral density measured by dual energy x-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone 1993; 14:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/28\">",
"      Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA 1992; 268:3333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/29\">",
"      van Daele PL, Stolk RP, Burger H, et al. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med 1995; 122:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/30\">",
"      Melton LJ 3rd, Riggs BL, Leibson CL, et al. A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab 2008; 93:4804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/31\">",
"      Strotmeyer ES, Cauley JA, Schwartz AV, et al. Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res 2004; 19:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/32\">",
"      Heath H 3rd, Melton LJ 3rd, Chu CP. Diabetes mellitus and risk of skeletal fracture. N Engl J Med 1980; 303:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/33\">",
"      Dobnig H, Piswanger-S&ouml;lkner JC, Roth M, et al. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 2006; 91:3355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/34\">",
"      Paganini-Hill A, Ross RK, Gerkins VR, et al. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981; 95:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/35\">",
"      Meyer HE, Tverdal A, Falch JA. Risk factors for hip fracture in middle-aged Norwegian women and men. Am J Epidemiol 1993; 137:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/36\">",
"      Kelsey JL, Browner WS, Seeley DG, et al. Risk factors for fractures of the distal forearm and proximal humerus. The Study of Osteoporotic Fractures Research Group. Am J Epidemiol 1992; 135:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/37\">",
"      Cundy TF, Edmonds ME, Watkins PJ. Osteopenia and metatarsal fractures in diabetic neuropathy. Diabet Med 1985; 2:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/38\">",
"      Wolf SK. Diabetes mellitus and predisposition to athletic pedal fracture. J Foot Ankle Surg 1998; 37:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/39\">",
"      Schwartz AV, Sellmeyer DE, Ensrud KE, et al. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 2001; 86:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/40\">",
"      Nicodemus KK, Folsom AR, Iowa Women's Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001; 24:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/41\">",
"      Ivers RQ, Cumming RG, Mitchell P, et al. Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 2001; 24:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/42\">",
"      Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 2005; 48:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/43\">",
"      Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int 2007; 18:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/44\">",
"      Bonds DE, Larson JC, Schwartz AV, et al. Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab 2006; 91:3404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/45\">",
"      Strotmeyer ES, Cauley JA, Schwartz AV, et al. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 2005; 165:1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/46\">",
"      Lipscombe LL, Jamal SA, Booth GL, Hawker GA. The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care 2007; 30:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/47\">",
"      Melton LJ 3rd, Leibson CL, Achenbach SJ, et al. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 2008; 23:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/48\">",
"      Yamamoto M, Yamaguchi T, Yamauchi M, et al. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res 2009; 24:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/49\">",
"      Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int 2009; 84:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/50\">",
"      Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007; 166:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/51\">",
"      Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002; 25:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/52\">",
"      Leslie WD, Lix LM, Prior HJ, et al. Biphasic fracture risk in diabetes: a population-based study. Bone 2007; 40:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/53\">",
"      Schwartz AV, Vittinghoff E, Bauer DC, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 2011; 305:2184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/54\">",
"      Giangregorio LM, Leslie WD, Lix LM, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 2012; 27:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/55\">",
"      Cozen L. Does diabetes delay fracture healing? Clin Orthop Relat Res 1972; 82:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/56\">",
"      Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res 1988; :210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/57\">",
"      Keegan TH, Schwartz AV, Bauer DC, et al. Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial. Diabetes Care 2004; 27:1547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/58\">",
"      Lunt H. Women and diabetes. Diabet Med 1996; 13:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11687/abstract/59\">",
"      R&auml;kel A, Sheehy O, Rahme E, LeLorier J. Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 2008; 34:193.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2051 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-EA0AF42627-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11687=[""].join("\n");
var outline_f11_26_11687=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BONE METABOLISM IN DIABETES MELLITUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BONE DENSITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Type 1 diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Type 2 diabetes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      FRACTURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fracture healing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PREVENTION AND TREATMENT OF OSTEOPOROSIS IN DIABETIC WOMEN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/2051\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/2051|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/21/3421\" title=\"table 1\">",
"      Effects diabetes bone",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/33/42519?source=related_link\">",
"      Bone physiology and biochemical markers of bone turnover",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/59/43960?source=related_link\">",
"      Diffuse idiopathic skeletal hyperostosis (DISH)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/35/43577?source=related_link\">",
"      Initial management of blood glucose in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22358?source=related_link\">",
"      Musculoskeletal complications in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/42/29354?source=related_link\">",
"      Osteoporotic fracture risk assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/50/18218?source=related_link\">",
"      Pathogenesis of renal osteodystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21290?source=related_link\">",
"      Thiazolidinediones in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31657?source=related_link\">",
"      Treatment of osteoporosis in men",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_26_11688="Primary biliary cirrhosis X - high power";
var content_f11_26_11688=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Primary biliary cirrhosis in a young woman who presented with pruritus one year after treatment with methotrexate (high power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A normal bile duct (arrow) is surrounded by connective tissue in a pattern reminiscent of the onion skin lesion that is characteristic of primary sclerosing cholangitis. There is fatty infiltration of some hepatocytes (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11688=[""].join("\n");
var outline_f11_26_11688=null;
var title_f11_26_11689="Candidiasis vulva";
var content_f11_26_11689=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70637%7EOBGYN%2F51710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70637%7EOBGYN%2F51710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 495px\">",
"   <div class=\"ttl\">",
"    Candidiasis vulva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 475px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from&nbsp;Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Candidiasis vulva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from&nbsp;Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11689=[""].join("\n");
var outline_f11_26_11689=null;
var title_f11_26_11690="Selective serotonin reuptake inhibitor poisoning";
var content_f11_26_11690=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Selective serotonin reuptake inhibitor poisoning",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/26/11690/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/26/11690/contributors\">",
"     Michael Ganetsky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/26/11690/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/26/11690/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/26/11690/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/26/11690/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/26/11690/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/26/11690/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The selective serotonin reuptake inhibitors (SSRIs) were introduced in the late 1980s for the treatment of depression. They are generally much safer in overdose than tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). Commonly used SSRIs include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    In 2008, single-substance SSRI ingestions accounted for 44,287 reported exposures to US poison centers, 90 major outcomes, and only two fatalities [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/1\">",
"     1",
"    </a>",
"    ]. The incidence of SSRI ingestions has steadily increased and mirrors the increase in SSRI prescriptions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/2\">",
"     2",
"    </a>",
"    ]. Isolated SSRI ingestions generally produce mild symptoms, although SSRI intoxication can infrequently produce serotonin syndrome, seizures, CNS depression, or various cardiac abnormalities.",
"   </p>",
"   <p>",
"    The toxicity and management of acute SSRI overdose will be discussed here. A summary table to facilitate emergent management of SSRI poisoning is provided (",
"    <a class=\"graphic graphic_table graphicRef82567 \" href=\"UTD.htm?7/39/7805\">",
"     table 1",
"    </a>",
"    ). Discussions of the therapeutic use of these medications, and of serotonin syndrome, are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=see_link\">",
"     \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serotonin is produced from tryptophan, while norepinephrine and dopamine are produced from tyrosine, through similar chemical pathways in nerve terminals. These neurotransmitters are stored in cytoplasmic vesicles of presynaptic neurons and released into the synapse with nerve depolarization. Transport proteins specific for serotonin, norepinephrine, or dopamine are embedded in the presynaptic terminal cell membrane and are responsible for pumping these neurotransmitters out of the synapse and back into the cytoplasm. Once in the cytoplasm, the neurotransmitters are either repackaged into vesicles for reuse or degraded by monoamine oxidase.",
"   </p>",
"   <p>",
"    Approximately 98 percent of the body's serotonin is found outside the central nervous system (CNS). Several families of serotonin receptors, with multiple subtypes, have been discovered. In the CNS, serotonergic neurons are found in the brainstem, mostly in the raphe nucleus. They have a role in regulating mood, personality, appetite, wakefulness, emesis, temperature regulation, and sexual behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/3\">",
"     3",
"    </a>",
"    ]. Peripherally, serotonin aids in regulating vascular tone, peristalsis, and platelet activation.",
"   </p>",
"   <p>",
"    The SSRIs inhibit the reuptake mechanism of serotonin in CNS neurons, as well as peripherally and in platelets, thereby increasing the stimulation of serotonin receptors. Compared with tricyclic antidepressants (TCAs) and other antidepressants, SSRIs are less effective at blocking reuptake of norepinephrine and likely less able to antagonize muscarinic, histaminergic, and adrenergic receptors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     KINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective serotonin reuptake inhibitors (SSRIs) are rapidly absorbed and reach a peak serum concentration within six hours (",
"    <a class=\"graphic graphic_table graphicRef67511 \" href=\"UTD.htm?10/59/11196\">",
"     table 2",
"    </a>",
"    ). Most SSRIs demonstrate a high degree of serum protein binding, and most have a long elimination half-life, with sustained biological activity due to active metabolites.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     Paroxetine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    are unusual in that they have no active metabolites. In overdose, SSRI elimination times are further prolonged by the saturation of metabolic enzymes and by delayed absorption, especially for sustained-release preparations.",
"   </p>",
"   <p>",
"    Due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    's active metabolite norfluoxetine and to the slow elimination of both, significant accumulation of these drugs and delays in reaching a steady state can occur. Significant serum concentrations can persist even four to five weeks after discontinuation of fluoxetine&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/4\">",
"     4",
"    </a>",
"    ]. This can result in adverse drug interactions and toxicity, if a new antidepressant or serotonergic medication is introduced for up to a month after fluoxetine is stopped (",
"    <a class=\"graphic graphic_table graphicRef67511 \" href=\"UTD.htm?10/59/11196\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    All SSRIs are metabolized in the liver by the cytochrome P450 system; most metabolites are renally excreted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES OF OVERDOSE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should seek answers to the following questions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Which drugs were ingested (including all coingestants and drug formulations, eg, sustained release)?",
"     </li>",
"     <li>",
"      What amount was ingested?",
"     </li>",
"     <li>",
"      When were the drugs ingested?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Every effort should be made to obtain this information, particularly if the patient is unable to provide a history due to alterations in mental status. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link&amp;anchor=H4#H4\">",
"     \"General approach to drug poisoning in adults\", section on 'Initial evaluation and treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with intentional ingestions often develop greater toxicity than those with accidental exposures, so it is important to ask the patient directly about his or her intentions. Information obtained from the overdose patient is often unreliable, and confirmation should be sought. Additional history, including comorbid conditions and signs and symptoms, should be elicited from the patient, family members, friends, emergency medical services (EMS) personnel, and police.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination begins with assessment and stabilization of the airway, breathing, and circulation. Next, the clinician should attempt to identify any possible toxidromes. Key parts of the physical exam are vital signs, mental status, pupil size, skin dryness and color, and bowel sounds. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link&amp;anchor=H4#H4\">",
"     \"General approach to drug poisoning in adults\", section on 'Initial evaluation and treatment'",
"    </a>",
"    .) Clinicians should look specifically for evidence of serotonin syndrome, including: hyperthermia; diaphoresis; slow, continuous, horizontal, eye movements (referred to as ocular clonus); hypertonia; hyperreflexia; tremor; and ankle clonus. Neuromuscular findings are generally more pronounced in the lower extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Overview of SSRI toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many studies comparing the ingestion of selective serotonin reuptake inhibitors (SSRIs) with other antidepressants have found that SSRIs rarely produce fatality or serious sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/5-9\">",
"     5-9",
"    </a>",
"    ]. SSRIs are significantly less toxic than tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). As an example, 31 to 32 percent of TCA ingestions require intubation, compared with 4 to 6 percent of SSRI ingestions. Similarly, 31 to 35 percent of TCA ingestions require intensive care unit admission, compared with 0 to 6 percent of SSRI ingestions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/5,7,10\">",
"     5,7,10",
"    </a>",
"    ]. One study found an incidence of 1.6 deaths per million SSRI prescriptions, compared with 34.8 for TCAs and 20 for MAOIs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is also important to note the potential disparity in toxicity between SSRIs and SNRIs (serotonin and norepinephrine reuptake inhibitors). SNRIs such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    have been associated with greater risk of significant toxicity and mortality in overdose. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=see_link\">",
"     \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    SSRIs have a wide therapeutic window: ingestion of up to 30 times the daily dose typically produces minor or no symptoms, while ingestion of 50 to 75 times the daily dose can cause vomiting, mild CNS depression, or tremor. Most fatalities are reported with either extremely large doses (greater than 150 times the daily dose) or with the presence of coingestants such as ethanol or benzodiazepines [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serotonin syndrome rarely occurs after isolated SSRI ingestions, but severe episodes can occur following either a mixed serotonergic ingestion or changes made in therapeutic SSRI dosing. Serotonin syndrome caused by isolated SSRI ingestion tends not be severe.",
"   </p>",
"   <p>",
"    SSRI ingestions are unlikely to cause seizures or severe CNS depression [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/5,10\">",
"     5,10",
"    </a>",
"    ]. Seizures have been noted to occur in 1 to 2 percent of SSRI overdoses, but they are typically short and self-limited [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SSRIs do not have significant cardiotoxicity. Unlike the TCAs, they are typically not associated with QRS prolongation or ventricular tachycardia. In a review of 469 isolated SSRI ingestions, bradycardia occurred in 8 percent of cases and tachycardia in 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"     10",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     Citalopram",
"    </a>",
"    is likely the most cardiotoxic SSRI: ingestion is associated with prolongation of the QTc interval, which can predispose a patient to torsade de pointes (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Citalopram'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Since SSRIs have little or no antagonism of muscarinic, histaminic, or adrenergic receptors, they do not typically cause anticholinergic symptoms, significant sedation, or hypotension.",
"   </p>",
"   <p>",
"    In therapeutic dosing, SSRIs (specifically",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    ) may cause hyponatremia, most likely via the syndrome of inappropriate antidiuretic hormone secretion (SIADH) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. The elderly appear to be at greatest risk of this complication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Serotonin syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serotonin syndrome is a clinical constellation of autonomic instability, mental status change, and increased neuromuscular tone caused by excessive stimulation of 5-HT1A and 5-HT2A receptors. It is typically caused by combining two or more serotonergic medications. Historically, MAOIs caused most cases, but SSRI interactions have become far more prevalent.",
"   </p>",
"   <p>",
"    Serotonin syndrome often occurs several days to one week after the addition of a new serotonergic agent or after the dose of a serotonergic agent is increased [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/3,15\">",
"     3,15",
"    </a>",
"    ]. Patients with SSRI overdose have a 10 to 14 percent incidence of serotonin syndrome, but many of these are mild presentations [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/5,10\">",
"     5,10",
"    </a>",
"    ]. In a study of 469 isolated SSRI ingestions,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    were most likely to cause a serotonin syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical findings critical to the diagnosis include: spontaneous or inducible muscle clonus; ocular clonus; agitation; diaphoresis; tremor; hyperreflexia; muscle rigidity; and hyperthermia. The syndrome can manifest a wide range of toxicity, and prognosis correlates with clinical findings. Patients with severe disease may develop acute hyperthermia (core temperature &gt;41.1&ordm;C), hypertension, tachycardia, agitated delirium, and muscle rigidity. Unless aggressive intervention is instituted promptly, these patients can go on to develop rhabdomyolysis, metabolic acidosis, renal failure, seizures, disseminated intravascular coagulation, and shock. A full discussion of serotonin syndrome is found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TOXICITY OF SPECIFIC AGENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Fluoxetine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     Fluoxetine",
"    </a>",
"    has been available longer than the other selective serotonin reuptake inhibitors (SSRIs), and many studies and reports exist supporting its safety in overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/11,16-19\">",
"     11,16-19",
"    </a>",
"    ]. Approximately half of fluoxetine ingestions remain asymptomatic, while the most frequently reported symptoms are nausea, vomiting, somnolence, tremor, agitation, and tachycardia. Most symptoms are benign and resolve quickly. Serious toxicity, such as dysrhythmias, seizures, central nervous system (CNS) depression, and respiratory arrest, is rare but can occur, especially when coingestants such as ethanol are present [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/11,18\">",
"     11,18",
"    </a>",
"    ]. Serious toxicity is typically attributed to the coingestant and not to fluoxetine.",
"   </p>",
"   <p>",
"    A prospective study assessing toxicity found",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    safer than tricyclic antidepressants (TCAs) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/20\">",
"     20",
"    </a>",
"    ]. Two deaths occurred out of 124 patients in the TCA group; no deaths occurred out of 16 patients in the fluoxetine group. Moreover, no fluoxetine patient developed seizures, QRS prolongation, hypotension, serotonin syndrome, or required intubation. Mild CNS depression was seen in five of the fluoxetine overdoses.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     Fluoxetine",
"    </a>",
"    overdose is well tolerated, even in very large amounts. Acute ingestions of 2 to 3 grams typically cause only minimal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/17,21\">",
"     17,21",
"    </a>",
"    ]. There are several reports of death attributed to fluoxetine overdose, but they involved ingestions of 6 to 12 grams [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. Fluoxetine serum concentrations were 2300 to 6000",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    in these patients, which is greater than most previously reported levels and significantly greater than the typical steady state therapeutic concentration of 250",
"    <span class=\"nowrap\">",
"     mcg/L.",
"    </span>",
"    Fluoxetine has been associated with a 1 percent incidence of developing serotonin syndrome in isolated ingestion, but rarely are cases severe [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"     10",
"    </a>",
"    ]. Most fatalities associated with fluoxetine overdose involve coingestants [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Case reports suggest that seizure should be considered a possible, albeit rare, complication of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10,17,22,25-28\">",
"     10,17,22,25-28",
"    </a>",
"    ]. In two cases, the onset of seizure was delayed 9 to 16 hours after the ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/26,28\">",
"     26,28",
"    </a>",
"    ]. However, in most cases, proconvulsant coingestants were either present or could not be excluded, and seizures tended to be brief and self-limited. During clinical trials, seizures rarely occurred in patients given therapeutic doses of fluoxetine [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/17,29\">",
"     17,29",
"    </a>",
"    ]. In three prospective or cohort studies of fluoxetine ingestions, only four seizures were observed in a pooled sample of 325 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10,18,20\">",
"     10,18,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     Fluoxetine",
"    </a>",
"    has minimal cardiotoxicity. Prolongation of the QTc interval of no greater than 450 msec was noted in 62 percent of fluoxetine overdose patients in one study, but none developed a ventricular dysrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/20\">",
"     20",
"    </a>",
"    ]. A prospective study of 32 fluoxetine ingestions found no ECG abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/19\">",
"     19",
"    </a>",
"    ]. Rare reports exist of sinus bradycardia, supraventricular tachycardia, atrial fibrillation, atrial flutter, ST segment depression, and ventricular tachycardia associated with fluoxetine [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10,27,30-34\">",
"     10,27,30-34",
"    </a>",
"    ]. There is one report of QT prolongation to 600 msec and torsade de pointes requiring cardioversion in a 74-year-old woman three weeks after starting therapeutic fluoxetine [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/35\">",
"     35",
"    </a>",
"    ]. In another report, a patient who ingested 2.4 grams of fluoxetine developed a TCA-like QRS interval prolongation that responded to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    administration [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/28\">",
"     28",
"    </a>",
"    ]. A patient who ingested 12 grams of fluoxetine developed bradycardia, which progressed to ventricular fibrillation and asystole [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/22\">",
"     22",
"    </a>",
"    ]. Nevertheless, in both therapeutic use and overdose, fluoxetine-associated cardiotoxicity remains rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Sertraline",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical trial and poison center data, various case reports, and several small studies suggest that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    is as safe in overdose as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/11,36-39\">",
"     11,36-39",
"    </a>",
"    ]. In a prospective poison center study of sertraline ingestions, 10 of 17 isolated overdoses had no signs or symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/39\">",
"     39",
"    </a>",
"    ]. Another poison center study found that 34 out of 52 isolated sertraline ingestions were asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/38\">",
"     38",
"    </a>",
"    ]. In these studies, the most common symptoms were nausea, tremor, and lethargy, while less common findings were agitation, vomiting, tachycardia, and bradycardia. Most symptoms resolved spontaneously within six hours [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Rare reports exist of brief, self-limited seizures and QTc prolongation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Sertraline has been associated with a 20 percent incidence of developing serotonin syndrome in isolated ingestion, but rarely are cases severe [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Paroxetine",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with the other SSRIs,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    is generally safe in overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/11,40\">",
"     11,40",
"    </a>",
"    ]. A poison center review noted that 8 out of 35 isolated paroxetine ingestions had no symptoms, while common symptoms included vomiting, drowsiness, tremors, dizziness, and sinus tachycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/41\">",
"     41",
"    </a>",
"    ]. Paroxetine has been associated rarely with brief, self-limited seizures and with an 18 percent incidence of developing serotonin syndrome in isolated ingestion, but rarely are cases severe [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of note, among SSRIs,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    has the highest rate of discontinuation syndrome because of its short half-life and lack of active metabolites. Symptoms are usually mild, lasting one to two weeks; they include nausea, dizziness, bad dreams, paresthesia, and a flu-like illness. Severe symptoms can occur and persist for prolonged periods, and may require restarting paroxetine [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26135?source=see_link\">",
"     \"Antidepressant medication in adults: Switching and discontinuing medication\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Fluvoxamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     Fluvoxamine",
"    </a>",
"    is generally safe in overdose. In a poison center study of 299 fluvoxamine ingestions, toxicity was benign when the dose ingested was less than 1000 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/43\">",
"     43",
"    </a>",
"    ]. Common symptoms of mild to moderate ingestions were drowsiness, tremor, diarrhea, vomiting, abdominal pain, dizziness, mydriasis, and sinus tachycardia. At higher doses, there were five seizures reported, as well as deeper levels of sedation, hypokalemia, hypotension, sinus bradycardia (never requiring treatment), and repolarization disorders. Thirteen deaths were reported, but they could all be attributed to coingestants or other medical problems. Among the 55 patients in whom fluvoxamine was the sole ingestant, only mild to moderate symptoms were evident, and the authors concluded that isolated overdoses of fluvoxamine rarely cause severe toxicity. In another study, fluvoxamine was associated with brief, self-limited seizures and with a 17 percent incidence of developing serotonin syndrome in isolated ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"     10",
"    </a>",
"    ]. Only rarely were these episodes of serotonin syndrome severe.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     Fluvoxamine",
"    </a>",
"    is associated with a discontinuation syndrome; symptoms can include dizziness, headache, nausea, and irritability [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26135?source=see_link\">",
"     \"Antidepressant medication in adults: Switching and discontinuing medication\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Citalopram",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     Citalopram",
"    </a>",
"    has the greatest potential for serious toxicity compared with other SSRIs. Citalopram is a racemic bicyclic phthalane derivative that is structurally different from the other SSRIs. It acts as a highly selective serotonin reuptake inhibitor, but unlike other SSRIs, also has anti-histaminergic properties [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    ingestions of less than 600 mg, symptoms tend to be mild and include nausea, dizziness, tachycardia, tremor, and somnolence [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. With larger ingestions, citalopram can cause serious cardiac and neurologic toxicity. It has been associated with a 9 percent incidence of serotonin syndrome in isolated ingestion, but rarely are cases severe [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"     10",
"    </a>",
"    ]. In rare instances, citalopram ingestions have been associated with metabolic acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Cardiotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anecdotal evidence and cohort analysis suggest that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    is the most cardiotoxic SSRI. With moderate (approximately 600 mg) to large (approximately 1900 mg) ingestions, citalopram has been associated with a variety of cardiac conduction disturbances.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     Citalopram",
"    </a>",
"    is hepatically metabolized to desmethylcitalopram (DCT) and the likely cardiotoxic metabolite didesmethylcitalopram (DDCT). Animal studies have shown a correlation between high serum levels of DDCT and both prolonged QTc and death [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In therapeutic dosing,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    has not been found to prolong the QTc interval nor was there a relationship noted between DDCT concentration and the QTc interval [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/50\">",
"     50",
"    </a>",
"    ]. In this study, however, the highest recorded serum DDCT concentration was approximately 100 times less than levels measured in overdose patients who developed QTc prolongation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/51\">",
"     51",
"    </a>",
"    ]. Therefore, it is difficult to extrapolate these results to poisoned patients.",
"   </p>",
"   <p>",
"    A poison center review of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    ingestions in Swedish hospitals identified 44 cases without coingestants [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/46\">",
"     46",
"    </a>",
"    ]. Of these, 6 of 18 patients who ingested greater than 600 mg developed a widened QRS complex, while all five patients who ingested greater than 1900 mg had either QRS widening, a seizure, or both. QRS changes were not seen immediately, and resolved within 24 hours. None of the patients had a clinically significant dysrhythmia. A follow-up to this study included 108 cases, in which 25 percent of patients had either ST segment changes or widening of ECG intervals, but again none had a clinically significant dysrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/47\">",
"     47",
"    </a>",
"    ]. Additional reviews have noted similar findings [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a logistic regression analysis of 57",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    ingestions compared with 240 other SSRI ingestions, citalopram was five times more likely to prolong the QTc interval beyond 440 msec [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"     10",
"    </a>",
"    ]. In the same study, the QTc was prolonged beyond 440 msec in 68 percent of cases and beyond 500 msec in 12 percent. QTc interval prolongation has been seen in patients who ingested as little as 400 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. In one of these reports, QTc prolongation was noted two hours after overdose, but it did not reach its peak until 13 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/53\">",
"     53",
"    </a>",
"    ]. There are only two reports of citalopram ingestions resulting in torsade de pointes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. In one of these reports, a patient developed intermittent torsades requiring intervention 36 hours after an ingestion of 1000 mg of citalopram [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other cardiac changes noted with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    ingestions include left bundle branch block [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10,47,54,57\">",
"     10,47,54,57",
"    </a>",
"    ], right bundle branch block [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/47\">",
"     47",
"    </a>",
"    ], ventricular extra beats [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/46\">",
"     46",
"    </a>",
"    ], sinus bradycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/58\">",
"     58",
"    </a>",
"    ], sinus tachycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/51\">",
"     51",
"    </a>",
"    ], supraventricular tachycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/59\">",
"     59",
"    </a>",
"    ], ST segment changes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/46,51\">",
"     46,51",
"    </a>",
"    ], and several case of ventricular fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/47,60\">",
"     47,60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical significance of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    's effects on cardiac conduction is unclear. Twelve fatalities have been attributed to overdoses of citalopram, but most involved coingestants [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/11,45,61\">",
"     11,45,61",
"    </a>",
"    ]. Although citalopram ingestions can cause a wide range of cardiac disturbances, patients typically do well with minimal intervention. Most patients with QRS or QTc prolongation recover within 24 hours with either supportive care or with bicarbonate infusion (to treat QRS prolongation).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Neurotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In clinical trials of therapeutic dosing, only 0.3 percent of patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    had a seizure, compared with 0.5 percent of patients taking placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/49\">",
"     49",
"    </a>",
"    ]. There are many reports, however, of citalopram ingestions causing seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10,46,47,51,52,54,57,59\">",
"     10,46,47,51,52,54,57,59",
"    </a>",
"    ]. Although one head-to-head comparison suggested that seizures are no more likely following ingestions of citalopram versus other SSRIs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"     10",
"    </a>",
"    ], other reviews are contradictory and placed the incidence of citalopram-induced seizures at 6 to 14 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/47,52\">",
"     47,52",
"    </a>",
"    ]. The risk of seizure appears to increase with the ingested dose. In a review of 108 patients, seizures were seen in 18 percent of patients who ingested 600 mg to 1900 mg, but in 47 percent of patients who ingested over 1900 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/47\">",
"     47",
"    </a>",
"    ]. In another case series, four out of five patients who ingested greater than 1400 mg developed seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/51\">",
"     51",
"    </a>",
"    ]. The majority of citalopram-induced seizures is brief and self-limited, and unlikely to result in neurologic sequelae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Escitalopram",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     Citalopram",
"    </a>",
"    is a racemic mixture of R- and S-citalopram;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"     escitalopram",
"    </a>",
"    is the pharmacologically active S-enantiomer and a more potent inhibitor of serotonin reuptake [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. Escitalopram toxicity appears to mimic that of citalopram and consists primarily of serotonin syndrome and QTc interval prolongation. Compared with citalopram, escitalopram seems to have greater serotonergic toxicity and less cardiac toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Citalopram'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    No serious toxicities or fatalities due to overdose were reported in clinical trials of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"     escitalopram",
"    </a>",
"    efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. However, postmarketing surveillance data includes reports of seizures, QTc prolongation, ventricular dysrhythmias, and serotonin syndrome, albeit without demonstration of a causal relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/64\">",
"     64",
"    </a>",
"    ]. Escitalopram appears to cause fewer seizures after overdose than does",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In overdose,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"     escitalopram",
"    </a>",
"    may cause serotonin toxicity, serotonin syndrome, and QTc prolongation, but there are no reports of torsades de pointes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/64,67-73\">",
"     64,67-73",
"    </a>",
"    ]. The best data related to overdose comes from a retrospective review of 79 escitalopram exposures. The authors report that significant serotonin toxicity (eg, hyperthermia) occurred in 15 percent of patients who ingested escitalopram only, while isolated serotonergic neuromuscular findings (eg, hyperreflexia) developed in as many as 46 percent. Tachycardia (42 percent), bradycardia (14 percent), and QTc interval abnormalities (14 percent) were also noted. A review of poison center data noted similar toxicity, in addition to somnolence, vomiting and tremors [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant toxicity in an isolated selective serotonin reuptake inhibitor (SSRI) ingestion is unlikely. If a patient is clinically sick or comatose, consider the presence of coingestants or an underlying non-toxicologic condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific serum drug concentrations are generally not helpful in assessing or managing selective serotonin reuptake inhibitor (SSRI) ingestions. As examples, one study of antidepressant overdose found no correlation between",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    levels and mental status, while a study of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    overdose found no correspondence between drug levels and symptom severity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/20,43\">",
"     20,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the setting of SSRI ingestion, routine laboratory evaluation should be targeted at possible coingestants and should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      and salicylate levels, to rule out these common coingestions",
"     </li>",
"     <li>",
"      Ethanol level; ethanol coingestion is associated with more severe toxicity",
"     </li>",
"     <li>",
"      Electrocardiogram, to rule out conduction system poisoning by drugs that effect the QRS or QTc intervals",
"     </li>",
"     <li>",
"      Serum bicarbonate to screen for metabolic acidosis",
"     </li>",
"     <li>",
"      Pregnancy test in women of childbearing age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients who develop serotonin syndrome with increased muscular tone or hyperthermia, the following laboratory information should be obtained:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Creatine kinase and urine myoglobin, to evaluate for rhabdomyolysis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"       \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Serum creatinine, to assess for kidney damage",
"     </li>",
"     <li>",
"      Serum aminotransferase concentrations, to assess for liver damage",
"     </li>",
"     <li>",
"      Coagulation studies (ie, aPTT, PT, INR, platelet count, d-dimer), to assess for disseminated intravascular coagulation (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Arterial blood gas, to assess for metabolic acidosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A summary table to facilitate emergent management of SSRI poisoning is provided (",
"    <a class=\"graphic graphic_table graphicRef82567 \" href=\"UTD.htm?7/39/7805\">",
"     table 1",
"    </a>",
"    ). Since most selective serotonin reuptake inhibitor (SSRI) ingestions develop minimal or no toxicity, the broad goal of management should be to provide supportive care and to minimize potentially unneeded and harmful interventions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .) Serotonin agonists, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    , must be avoided in patients with SSRI ingestions or in those who have serotonin syndrome, so as not to precipitate worse toxicity. Most patients with SSRI ingestions have good outcomes with supportive care alone. Victims of minor, accidental exposures that are asymptomatic can be observed at home.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Airway, breathing, and circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The airway should be secured with endotracheal intubation in patients who are obtunded and cannot protect their airway. Hypoventilation, hypoperfusion, and unstable dysrhythmias must be addressed early according to standard advanced cardiac life support (ACLS) protocols. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=see_link\">",
"     \"Advanced cardiac life support (ACLS) in adults\"",
"    </a>",
"    .) For wide QRS complex tachycardia,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    boluses can be given, followed by a bicarbonate infusion, if there is subsequent narrowing of the QRS complex. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36231?source=see_link&amp;anchor=H15#H15\">",
"     \"Tricyclic antidepressant poisoning\", section on 'Sodium bicarbonate'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizures typically respond to treatment with benzodiazepines, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A single dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"     activated charcoal",
"    </a>",
"    (AC) should be administered for gastrointestinal (GI) decontamination. The typical dose is 50 g in adults and 1",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    in children. The greatest benefit from charcoal decontamination occurs if given within one to two hours following the ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In retrospective observational studies, a single dose of AC was associated with a lower rate of QTc interval prolongation in",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"     escitalopram",
"    </a>",
"    overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/75,76\">",
"     75,76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Due to the rapid absorption of SSRIs, there is no role for multiple dose charcoal or charcoal additives such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39140?source=see_link\">",
"     magnesium citrate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    . Charcoal should be withheld in patients who are sedated and may not be able to protect their airway, unless endotracheal intubation is performed first. However, endotracheal intubation should not be performed solely for the purpose of giving charcoal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link\">",
"     \"Gastrointestinal decontamination of poisoned adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no role for extracorporeal removal techniques, such as hemodialysis, because SSRIs are highly bound to serum proteins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Serotonin syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who develop serotonin syndrome are treated with supportive care, discontinuation of the offending agent, and, depending upon the severity of illness, a serotonin antagonist, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/25/19862?source=see_link\">",
"     cyproheptadine",
"    </a>",
"    . Severe cases of serotonin syndrome that develop muscular rigidity and a core temperature greater than 41&ordm;C must be treated aggressively with neuromuscular paralysis, endotracheal intubation, and external cooling to prevent complications. A complete discussion of serotonin syndrome is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     QTc interval prolongation",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with SSRI ingestion and a prolonged QTc interval should have",
"    <strong>",
"     serial",
"    </strong>",
"    electrocardiograms (ECGs) to be certain the interval is not continuing to lengthen. A prolonged QTc interval predisposes to torsade de pointes, an intermittent ventricular dysrhythmia that can, albeit rarely, degenerate into potentially life-threatening monomorphic ventricular tachycardia or fibrillation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the QTc interval is significantly prolonged (greater than 560 msec), and other concerning signs are present (eg, frequent premature ventricular contractions), or magnesium therapy is instituted, ECGs should initially be performed every one to two hours. As the QTc interval narrows, ECGs can be obtained every four to eight hours until the interval normalizes (440 msec). Patients who will not be admitted should have a final ECG prior to discharge that demonstrates normal intervals.",
"   </p>",
"   <p>",
"    Warning signs indicating an increased risk of torsade de pointes (torsades) include: a QTc interval greater than 560 msec, previous history of torsades, bradycardia, increased frequency and complexity of ventricular premature beats, or a ventricular premature beat falling on the T-wave [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/77\">",
"     77",
"    </a>",
"    ]. Magnesium therapy to prevent torsades should be given to patients with any of these findings. The dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    in adults is 2 g over two minutes, which can be repeated after 10 to 15 minutes if the rhythm is not terminated. If there is clinical effect, a magnesium infusion at a rate of 2 to 10",
"    <span class=\"nowrap\">",
"     mg/min",
"    </span>",
"    may be helpful until the QTc interval is less than 500 msec. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link&amp;anchor=H20#H20\">",
"     \"Acquired long QT syndrome\", section on 'Acute therapy of TdP'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Observation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients can be referred to psychiatry after a four to six hour observation period if they are asymptomatic and have not developed any ECG changes, particularly prolongation of the QTc. Massive ingestions (ie, those greater than 150 times the daily dose of the SSRI) should be admitted for 24 hours of cardiac monitoring, since these are at greatest risk for severe toxicity.",
"   </p>",
"   <p>",
"    Because",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"     escitalopram",
"    </a>",
"    potentially have a cardiotoxic metabolite, patients with these ingestions should receive an ECG at least six hours after their ingestion. If these patients have any signs of QTc or QRS prolongation, or have experienced a dysrhythmia, they should be admitted for cardiac monitoring until their ECG intervals normalize.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     PEDIATRIC CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric ingestions of selective serotonin reuptake inhibitors (SSRIs) are generally well tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/16\">",
"     16",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     Fluoxetine",
"    </a>",
"    caused either no or minimal symptoms (sleepiness, hyperactivity, and diarrhea) in 20 pediatric ingestions in one prospective study [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/18\">",
"     18",
"    </a>",
"    ]. A retrospective poison center review identified 120 cases of isolated fluoxetine ingestions in children less than six years of age; 116 were asymptomatic, three had emesis, and one was sedated [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/78\">",
"     78",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     Sertraline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    also produce minimal toxicity. Several studies noted that most patients are asymptomatic; those that are symptomatic most commonly manifest CNS stimulation, drowsiness, dizziness, vomiting, or sinus tachycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/38,41,79,80\">",
"     38,41,79,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Little data exist on the safety of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    in pediatric ingestions. There is one case report of a child of four years requiring intubation for CNS depression and vasopressor support for hypotension following a 400 mg ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/81\">",
"     81",
"    </a>",
"    ]. There are several reports of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    and fluvoxamine ingestions causing serotonin syndrome in children [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/82-84\">",
"     82-84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Case reports suggest that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/25/19862?source=see_link\">",
"     cyproheptadine",
"    </a>",
"    can be used to treat serotonin syndrome in children [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/82\">",
"     82",
"    </a>",
"    ]. The pediatric dose of cyproheptadine is 0.25",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day divided twice or three times daily up to a maximum dose of 12 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relationship between SSRIs and increased risk of suicide among pediatric patients is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/23/15736?source=see_link\">",
"     \"Effect of antidepressants on suicide risk in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Maternal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    use has been associated with a hyperserotonergic state in neonates and in breast-feeding infants [",
"    <a class=\"abstract\" href=\"UTD.htm?11/26/11690/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. In newborns, serotonergic symptoms can manifest as fever, somnolence, jitteriness, irritability, tremors, and a hyperactive Moro (ie, startle) reflex. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28682?source=see_link&amp;anchor=H7#H7\">",
"     \"Depression in pregnant women: Management\", section on 'SSRIs and SNRIs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13369077\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/482?source=see_link\">",
"       \"Patient information: Serotonin syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective serotonin reuptake inhibitors (SSRIs) are generally well tolerated in overdose and are much safer than other antidepressant medications such as tricyclic antidepressants (TCAs). Toxicity is most commonly due to coingestants. A summary table to facilitate the emergent management of SSRI poisoning is provided (",
"    <a class=\"graphic graphic_table graphicRef82567 \" href=\"UTD.htm?7/39/7805\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinicians should aggressively seek answers to the following questions when treating SSRI ingestions (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link&amp;anchor=H4#H4\">",
"       \"General approach to drug poisoning in adults\", section on 'Initial evaluation and treatment'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Which drugs were ingested (including all coingestants and drug formulations, eg sustained release)?",
"     </li>",
"     <li>",
"      What amount was ingested?",
"     </li>",
"     <li>",
"      When were the drugs ingested?",
"      <br/>",
"      <br/>",
"      Victims of intentional ingestions often develop greater toxicity than accidental exposures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Examination begins with assessment and stabilization of the airway, breathing, and circulation. Next, the clinician should attempt to identify any possible toxidromes. Key parts of the physical exam are vital signs, mental status, pupil size, skin dryness and color, and bowel sounds. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link&amp;anchor=H4#H4\">",
"       \"General approach to drug poisoning in adults\", section on 'Initial evaluation and treatment'",
"      </a>",
"      .) Clinicians should look specifically for evidence of serotonin syndrome, including: hyperthermia, diaphoresis, ocular clonus, hypertonia, hyperreflexia, tremor, and ankle clonus. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical features of overdose'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Serotonin syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Specific serum drug concentrations are generally not helpful in assessing or managing SSRI ingestions. Routine laboratory evaluation should be targeted at possible coingestants and should include the following (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Laboratory evaluation'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      and salicylate levels",
"     </li>",
"     <li>",
"      Ethanol level",
"     </li>",
"     <li>",
"      Electrocardiogram, to rule out conduction system poisoning",
"     </li>",
"     <li>",
"      Serum bicarbonate to screen for metabolic acidosis",
"     </li>",
"     <li>",
"      Pregnancy test in women of childbearing age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Since most SSRI ingestions develop minimal or no toxicity, the broad goal of management should be to provide supportive care and to minimize potentially unneeded and harmful interventions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"       \"General approach to drug poisoning in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest that a single dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"       activated charcoal",
"      </a>",
"      (AC) be administered for gastrointestinal (GI) decontamination. (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). The typical dose is 50 g in adults and 1",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      in children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link\">",
"       \"Gastrointestinal decontamination of poisoned adults\"",
"      </a>",
"      .) The greatest benefit from charcoal decontamination occurs if given within one to two hours following the ingestion. Because of the potential risk of aspiration and the lack of benefit, we recommend that multiple dose charcoal and charcoal additives such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39140?source=see_link\">",
"       magnesium citrate",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"       sorbitol",
"      </a>",
"      &nbsp;",
"      <strong>",
"       NOT",
"      </strong>",
"      be given. (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Charcoal should be withheld in patients who are sedated and may not be able to protect their airway, unless endotracheal intubation is performed first. Endotracheal intubation should not be performed solely for the purpose of giving charcoal. There is no role for extracorporeal removal techniques, such as hemodialysis. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Decontamination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SSRIs rarely produce fatality or serious sequelae, mainly due to their wide therapeutic window: ingestion of up to 30 times the daily dose typically produces minor or no symptoms, while ingestion of 50 to 75 times the daily dose can cause vomiting, mild central nervous system (CNS) depression, or tremor. Most fatalities are reported with either extremely large doses (greater than 150 times the daily dose) or with the presence of coingestants such as ethanol, benzodiazepines, or tricyclic antidepressants. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Overview of SSRI toxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serotonin syndrome rarely occurs after isolated SSRI ingestions, but severe episodes can occur following either a mixed serotonergic ingestion or changes made in therapeutic SSRI dosing. Serotonin syndrome caused by isolated SSRI ingestion tends not be severe.",
"     </li>",
"     <li>",
"      Although such complications are rare, SSRI ingestions can cause seizures or prolonged ECG intervals, predisposing to dysrhythmias.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"       Citalopram",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"       escitalopram",
"      </a>",
"      are most likely to cause abnormal cardiac conduction. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Citalopram'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Escitalopram'",
"      </a>",
"      above.) For wide QRS complex tachycardia associated with ingestion of these agents, we suggest treatment with boluses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      , followed by a bicarbonate infusion, if there is subsequent narrowing of the QRS complex. (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36231?source=see_link&amp;anchor=H15#H15\">",
"       \"Tricyclic antidepressant poisoning\", section on 'Sodium bicarbonate'",
"      </a>",
"      .) Seizures typically respond to treatment with benzodiazepines, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"       lorazepam",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      All patients with SSRI ingestion and a prolonged QTc interval should have",
"      <strong>",
"       serial",
"      </strong>",
"      ECGs to be certain the interval is not continuing to lengthen. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'QTc interval prolongation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Significant serum concentrations of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      can persist even four to five weeks after discontinuation of the drug. This can result in adverse drug interactions and toxicity if a new antidepressant or serotonergic medication is introduced for up to a month after fluoxetine is stopped (",
"      <a class=\"graphic graphic_table graphicRef67511 \" href=\"UTD.htm?10/59/11196\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Fluoxetine'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/1\">",
"      Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila) 2009; 47:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/2\">",
"      Townsend E, Hawton K, Harriss L, et al. Substances used in deliberate self-poisoning 1985-1997: trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol 2001; 36:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/3\">",
"      Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352:1112.",
"     </a>",
"    </li>",
"    <li>",
"     Prozac Package Insert 2005. Eli Lilly and Company (www.lilly.com).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/5\">",
"      Graudins A, Dowsett RP, Liddle C. The toxicity of antidepressant poisoning: is it changing? A comparative study of cyclic and newer serotonin-specific antidepressants. Emerg Med (Fremantle) 2002; 14:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/6\">",
"      Mason J, Freemantle N, Eccles M. Fatal toxicity associated with antidepressant use in primary care. Br J Gen Pract 2000; 50:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/7\">",
"      Stoner SC, Marken PA, Watson WA, et al. Antidepressant overdoses and resultant emergency department services: the impact of SSRIs. Psychopharmacol Bull 1997; 33:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/8\">",
"      Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/9\">",
"      Buckley NA, McManus PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002; 325:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/10\">",
"      Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004; 42:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/11\">",
"      Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry 1998; 59 Suppl 15:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/12\">",
"      Fabian TJ, Amico JA, Kroboth PD, et al. Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Geriatr Psychiatry Neurol 2003; 16:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/13\">",
"      Movig KL, Leufkens HG, Lenderink AW, et al. Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol 2002; 53:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/14\">",
"      Nahshoni E, Weizman A, Shefet D, Pik N. A case of hyponatremia associated with escitalopram. J Clin Psychiatry 2004; 65:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/15\">",
"      Ganetsky, M, Brush, E. Serotonin syndrome - what have we learned? Clin Ped Emerg Med 2005; 6:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/16\">",
"      Spiller HA, Morse S, Muir C. Fluoxetine ingestion: a one year retrospective study. Vet Hum Toxicol 1990; 32:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/17\">",
"      Wernicke JF. The side effect profile and safety of fluoxetine. J Clin Psychiatry 1985; 46:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/18\">",
"      Borys DJ, Setzer SC, Ling LJ, et al. Acute fluoxetine overdose: a report of 234 cases. Am J Emerg Med 1992; 10:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/19\">",
"      Chiang, WK, Ford, MK, Wax, PM, et al. Prospective evaluation of fluoxetine ingestions (abstract). Vet Hum Toxicol 1990; 32:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/20\">",
"      Phillips S, Brent J, Kulig K, et al. Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdoses. The Antidepressant Study Group. J Emerg Med 1997; 15:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/21\">",
"      Moore JL, Rodriguez R. Toxicity of fluoxetine in overdose. Am J Psychiatry 1990; 147:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/22\">",
"      Compton R, Spiller HA, Bosse GM. Fatal fluoxetine ingestion with postmortem blood concentrations. Clin Toxicol (Phila) 2005; 43:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/23\">",
"      Kincaid RL, McMullin MM, Crookham SB, Rieders F. Report of a fluoxetine fatality. J Anal Toxicol 1990; 14:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/24\">",
"      Rohrig TP, Prouty RW. Fluoxetine overdose: a case report. J Anal Toxicol 1989; 13:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/25\">",
"      Gross R, Dannon PN, Lepkifker E, et al. Generalized seizures caused by fluoxetine overdose. Am J Emerg Med 1998; 16:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/26\">",
"      Braitberg G, Curry SC. Seizure after isolated fluoxetine overdose. Ann Emerg Med 1995; 26:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/27\">",
"      Riddle MA, Brown N, Dzubinski D, et al. Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 1989; 28:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/28\">",
"      Graudins A, Vossler C, Wang R. Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy. Am J Emerg Med 1997; 15:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/29\">",
"      Cooper GL. The safety of fluoxetine--an update. Br J Psychiatry Suppl 1988; :77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/30\">",
"      Gardner SF, Rutherford WF, Munger MA, Panacek EA. Drug-induced supraventricular tachycardia: a case report of fluoxetine. Ann Emerg Med 1991; 20:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/31\">",
"      Roberge RJ, Martin TG. Mixed fluoxetine/loxapine overdose and atrial flutter. Ann Emerg Med 1994; 23:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/32\">",
"      McAnally LE, Threlkeld KR, Dreyling CA. Case report of a syncopal episode associated with fluoxetine. Ann Pharmacother 1992; 26:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/33\">",
"      Ahmed I, Dagincourt PG, Miller LG, Shader RI. Possible interaction between fluoxetine and pimozide causing sinus bradycardia. Can J Psychiatry 1993; 38:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/34\">",
"      Hofman, M, Liu, JK. Conduction abnormality and ventricular tachyarrhythmia associated with fluoxetine overdose (abstract). Vet Hum Toxicol 1994; 36:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/35\">",
"      Appleby M, Mbewu A, Clarke B. Fluoxetine and ventricular torsade--is there a link? Int J Cardiol 1995; 49:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/36\">",
"      Doogan DP. Toleration and safety of sertraline: experience worldwide. Int Clin Psychopharmacol 1991; 6 Suppl 2:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/37\">",
"      Caracci G. Unsuccessful suicide attempt by sertraline overdose. Am J Psychiatry 1994; 151:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/38\">",
"      Klein-Schwartz W, Anderson B. Analysis of sertraline-only overdoses. Am J Emerg Med 1996; 14:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/39\">",
"      Lau GT, Horowitz BZ. Sertraline overdose. Acad Emerg Med 1996; 3:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/40\">",
"      Boyer WF, Blumhardt CL. The safety profile of paroxetine. J Clin Psychiatry 1992; 53 Suppl:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/41\">",
"      Myers, LB, Dean, BS, Krenelok, EP. Paroxetine (Paxil): overdose assessment of a new selective serotonin reuptake inhibitor (abstract). Vet Hum Toxicol 1994; 36:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/42\">",
"      Tonks A. Withdrawal from paroxetine can be severe, warns FDA. BMJ 2002; 324:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/43\">",
"      Garnier R, Azoyan P, Chataigner D, et al. Acute fluvoxamine poisoning. J Int Med Res 1993; 21:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/44\">",
"      Black DW, Wesner R, Gabel J. The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 1993; 54:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/45\">",
"      Tan JY, Levin GM. Citalopram in the treatment of depression and other potential uses in psychiatry. Pharmacotherapy 1999; 19:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/46\">",
"      Personne M, Sj&ouml;berg G, Persson H. Citalopram overdose--review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol 1997; 35:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/47\">",
"      Personne M, Persson H, Sj&ouml;berg E. Citalopram toxicity. Lancet 1997; 350:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/48\">",
"      Bin Salih S, Al Qahtani M, Al Anazi T, et al. Metabolic acidosis and generalized seizures secondary to citalopram overdose: a case report. J Clin Pharm Ther 2010; 35:479.",
"     </a>",
"    </li>",
"    <li>",
"     Celexa Package Insert (2005). Forest Pharmaceuticals, file://www.frx.com/pi/celexa_pi.pdf (Accessed March 23, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/50\">",
"      Rasmussen SL, Over&oslash; KF, Tangh&oslash;j P. Cardiac safety of citalopram: prospective trials and retrospective analyses. J Clin Psychopharmacol 1999; 19:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/51\">",
"      Grundemar L, Wohlfart B, Lagerstedt C, et al. Symptoms and signs of severe citalopram overdose. Lancet 1997; 349:1602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/52\">",
"      Kelly CA, Dhaun N, Laing WJ, et al. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 2004; 42:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/53\">",
"      Catalano G, Catalano MC, Epstein MA, Tsambiras PE. QTc interval prolongation associated with citalopram overdose: a case report and literature review. Clin Neuropharmacol 2001; 24:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/54\">",
"      Engebretsen KM, Harris CR, Wood JE. Cardiotoxicity and late onset seizures with citalopram overdose. J Emerg Med 2003; 25:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/55\">",
"      Meuleman C, Jourdain P, Bellorini M, et al. [Citalopram and Torsades de Pointes. A case report]. Arch Mal Coeur Vaiss 2001; 94:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/56\">",
"      Tarabar, AF, Hoffman, RS, Nelson, LS. Citalopram overdose: late presentation of Torsades de Pointes (TdP) with cardiac arrest (abstract #86). J Toxicol Clin Toxicol 2003; 41:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/57\">",
"      Snider RD. Case report: left bundle branch block--a rare complication of citalopram overdose. J S C Med Assoc 2001; 97:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/58\">",
"      Rothenh&auml;usler HB, Hoberl C, Ehrentrout S, et al. Suicide attempt by pure citalopram overdose causing long-lasting severe sinus bradycardia, hypotension and syncopes: successful therapy with a temporary pacemaker. Pharmacopsychiatry 2000; 33:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/59\">",
"      Cuenca PJ, Holt KR, Hoefle JD. Seizure secondary to citalopram overdose. J Emerg Med 2004; 26:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/60\">",
"      Liotier J, Coudor&eacute; F. Drug monitoring of a case of citalopram overdosage. Drug Chem Toxicol 2011; 34:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/61\">",
"      Ostr&ouml;m M, Eriksson A, Thorson J, Spigset O. Fatal overdose with citalopram. Lancet 1996; 348:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/62\">",
"      Escitalopram (lexapro) for depression. Med Lett Drugs Ther 2002; 44:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/63\">",
"      van Gorp F, Whyte IM, Isbister GK. Clinical and ECG effects of escitalopram overdose. Ann Emerg Med 2009; 54:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/64\">",
"      Barnett, AK, Brush, DE, Schroeder, W. The pharmacology and toxicology of escitalopram. Int J Med Toxicol 2003; 6:14.",
"     </a>",
"    </li>",
"    <li>",
"     Lexapro Package Insert (2005), Forest Pharmaceuticals, file://www.frx.com/pi/lexapro_pi.pdf (Accessed March 23, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/66\">",
"      Yilmaz Z, Ceschi A, Rauber-L&uuml;thy C, et al. Escitalopram causes fewer seizures in human overdose than citalopram. Clin Toxicol (Phila) 2010; 48:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/67\">",
"      Abstracts of the North American Congress of Clinical Toxicology Annual Meeting. September 4-9, 2003. Chicago, Illinois, USA. J Toxicol Clin Toxicol 2003; 41:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/68\">",
"      Ginsburg, BY, Wiener, SW, Henderson, KJ, et al. QTc interval prolongation associated with escitalopram overdose (abstract #174). J Toxicol Clin Toxicol 2005; 43:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/69\">",
"      Scharko AM, Schumacher J. Prolonged QTc interval in a 14-year-old girl with escitalopram overdose. J Child Adolesc Psychopharmacol 2008; 18:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/70\">",
"      Yuksel FV, Tuzer V, Goka E. Escitalopram intoxication. Eur Psychiatry 2005; 20:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/71\">",
"      Olsen, DG, Dart, RC, Robinett, M. Severe serotonin syndrome from escitalopram overdose. J Toxicol Clin Toxicol 2004; 42:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/72\">",
"      Huska MT, Catalano G, Catalano MC. Serotonin syndrome associated with the use of escitalopram. CNS Spectr 2007; 12:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/73\">",
"      Lindgren, KN, et al. Escitalopram, a review of adverse effects in overdose reported to select regional poison centers (abstract #41). J Toxicol Clin Toxicol 2003; 41:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/74\">",
"      Chyka PA, Seger D, Krenzelok EP, et al. Position paper: Single-dose activated charcoal. Clin Toxicol 2005; 43:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/75\">",
"      Isbister GK, Friberg LE, Stokes B, et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med 2007; 50:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/76\">",
"      van Gorp F, Duffull S, Hackett LP, Isbister GK. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal. Br J Clin Pharmacol 2012; 73:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/77\">",
"      Keren A, Tzivoni D. Torsades de pointes: prevention and therapy. Cardiovasc Drugs Ther 1991; 5:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/78\">",
"      Baker SD, Morgan DL. Fluoxetine exposures: are they safe for children? Am J Emerg Med 2004; 22:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/79\">",
"      Myers, LB, Dean, BS, Krenzelok, EP. Sertraline (Zoloft): a pediatric overdose approach (abstract). Vet Human Toxicol 1994; 36:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/80\">",
"      Myers LB, Krenzelok EP. Paroxetine (Paxil) overdose: a pediatric focus. Vet Hum Toxicol 1997; 39:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/81\">",
"      Fraser J, South M. Life-threatening fluvoxamine overdose in a 4-year-old child. Intensive Care Med 1999; 25:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/82\">",
"      Horowitz BZ, Mullins ME. Cyproheptadine for serotonin syndrome in an accidental pediatric sertraline ingestion. Pediatr Emerg Care 1999; 15:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/83\">",
"      Kaminski CA, Robbins MS, Weibley RE. Sertraline intoxication in a child. Ann Emerg Med 1994; 23:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/84\">",
"      Gill M, LoVecchio F, Selden B. Serotonin syndrome in a child after a single dose of fluvoxamine. Ann Emerg Med 1999; 33:457.",
"     </a>",
"    </li>",
"    <li>",
"     Mosby. Mosby's Drug Consult: A Comprehensive Reference for Brand and Generic Prescription Drugs, Mosby, Philadelphia 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/86\">",
"      Hale TW, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr (Phila) 2001; 40:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/26/11690/abstract/87\">",
"      Isbister GK, Dawson A, Whyte IM, et al. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Arch Dis Child Fetal Neonatal Ed 2001; 85:F147.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 297 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-94E968098A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11690=[""].join("\n");
var outline_f11_26_11690=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      KINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES OF OVERDOSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Overview of SSRI toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TOXICITY OF SPECIFIC AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Fluoxetine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Sertraline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Paroxetine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Fluvoxamine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Citalopram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Cardiotoxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Neurotoxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Escitalopram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Airway, breathing, and circulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      QTc interval prolongation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Observation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      PEDIATRIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13369077\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/297\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/297|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/39/7805\" title=\"table 1\">",
"      Overview of selective serotonin reuptake inhibitor poisoning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/59/11196\" title=\"table 2\">",
"      SSRI kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=related_link\">",
"      Advanced cardiac life support (ACLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26135?source=related_link\">",
"      Antidepressant medication in adults: Switching and discontinuing medication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=related_link\">",
"      Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28682?source=related_link\">",
"      Depression in pregnant women: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/23/15736?source=related_link\">",
"      Effect of antidepressants on suicide risk in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=related_link\">",
"      Gastrointestinal decontamination of poisoned adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/482?source=related_link\">",
"      Patient information: Serotonin syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=related_link\">",
"      Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=related_link\">",
"      Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36231?source=related_link\">",
"      Tricyclic antidepressant poisoning",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_26_11691="Laboratory studies for pediatric hypertensive emergencies";
var content_f11_26_11691=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommended studies in children with hypertensive emergencies*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       All patients",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Serum BUN, creatinine, electrolytes, and glucose",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Complete blood count with reticulocyte count",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Microscopic urinalysis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       EKG",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chest radiograph",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Selected patients",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Urine toxicology screen for amphetamines, PCP, cocaine metabolites",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Urine pregnancy test",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Head CT",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BUN: blood urea nitrogen; EKG: electrocardiogram; PCP: phencyclidine; CT: computed tomography.",
"     <br>",
"      * Additional specialized diagnostic testing may be deferred until blood pressure is controlled.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11691=[""].join("\n");
var outline_f11_26_11691=null;
var title_f11_26_11692="Criteria substance dependence";
var content_f11_26_11692=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F50295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F50295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    DSM-IV-TR criteria for substance dependence",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        A maladaptive pattern of substance use, leading to clinically significant impairment or distress, as manifested by three (or more) of the following, occurring at any time in the same 12-month period:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Tolerance, as defined by either of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        A need for markedly increased amounts of the substance to achieve intoxication or desired effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Markedly diminished effect with continued use of the same amount of the substance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Withdrawal, as manifested by any of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The characteristic withdrawal syndrome for the substance (refer to Criteria A and B of the criteria sets for Withdrawal from the specific substances)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The same (or a closely related) substance is taken to relieve or avoid withdrawal symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The substance is often taken in larger amounts or over a longer period than was intended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        There is a persistent desire or unsuccessful efforts to cut down or control substance use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        A great deal of time is spent in activities necessary to obtain the substance (eg, visiting multiple doctors or driving long distances), use the substance (eg, chain-smoking), or recover from its effects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Important social, occupational, or recreational activities are given up or reduced because of substance use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance (eg, current cocaine use despite recognition of cocaine-induced depression, or continued drinking despite recognition that an ulcer was made worse by alcohol consumption)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Text Revision, Fourth Edition. Copyright &copy; 2000 American Psychiatric Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11692=[""].join("\n");
var outline_f11_26_11692=null;
var title_f11_26_11693="Bone fractures post heart transplant";
var content_f11_26_11693=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F79240&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F79240&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fractures occur early after cardiac transplantation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 424px; height: 299px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Time to first bone fracture in men and postmenopausal women who sustained a fracture after cardiac transplantation. Fracture occurred in 36 percent of all patients and 54 percent of women; 85 percent of the fractures occurred within the first six months.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Shane E, Rivas M, Staron RB, et al. Fracture after cardiac transplantation: a prospective longitudinal study.&nbsp;J Clin Endocrinol Metab 1996; 81:1740.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11693=[""].join("\n");
var outline_f11_26_11693=null;
var title_f11_26_11694="Examination clues IEM";
var content_f11_26_11694=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physical examination findings as clues to inborn errors of metabolism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Finding",
"       </td>",
"       <td class=\"subtitle1\">",
"        Potential inborn error",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        General",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tall, long-limbed body habitus",
"       </td>",
"       <td>",
"        Homocystinuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Head",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Coarse facial features (eg, hirsuitism, prominent brow ridge, and gingival hypertrophy)",
"       </td>",
"       <td>",
"        Oligosaccharidoses, mucopolysaccharidoses, mucolipidoses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Microcephaly",
"       </td>",
"       <td>",
"        Untreated phenylketonuria (PKU), maternal PKU syndrome, congenital disorders of glycosylation, leukodystrophies (late), organic acidemias, urea cycle disorders, maple syrup urine disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Macrocephaly",
"       </td>",
"       <td>",
"        Canavan disease, glutaric acidemia type I, oligosaccharidoses, mucopolysaccharidoses, mucolipidoses, Tay-Sachs (early)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Hair",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alopecia",
"       </td>",
"       <td>",
"        Biotinidase deficiency, Vitamin D resistant rickets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sparse",
"       </td>",
"       <td>",
"        Biotinidase deficiency, Menkes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Kinky, brittle",
"       </td>",
"       <td>",
"        Argininosuccinic aciduria and citrullinemia (due to arginine deficiency), Menkes, mucopolysaccharidoses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Eyes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cataracts",
"       </td>",
"       <td>",
"        Oligosaccharidoses, Fabry disease, neuronal ceroid lipofuscinosis, galactosemia, Smith-Lemli-Opitz syndrome peroxisome biogenesis defects, rhizomelic chondrodysplasia punctata, Wilson disease, mitochondrial disorders, Lowe syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cherry red spot",
"       </td>",
"       <td>",
"        Tay-Sachs disease, Sandhoff disease, Sialidosis type I and type II, GM1-gangliosidosis, Niemann-Pick disease type A, Gaucher disease type 2, metachromatic leukodystrophy, galactosialidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Corneal clouding",
"       </td>",
"       <td>",
"        Oligosaccharidoses, mucopolysaccharidoses, mucolipidoses, Tangier, sialidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Corneal opacity",
"       </td>",
"       <td>",
"        Oligosaccharidoses, Fabry disease, steroid sulfatase deficiency (X-linked ichthyosis), Tangier, molybdenum cofactor deficiency, sulfite oxidase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dislocated lens",
"       </td>",
"       <td>",
"        Homocystinuria, sulfite oxidase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Kayser-Fleischer rings",
"       </td>",
"       <td>",
"        Wilson disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Retitinitis pigmentosa",
"       </td>",
"       <td>",
"        Abetalipoproteinemia, peroxisome biogenesis disorders, congenital disorders of glycosylation, fatty acid oxidation defects, mitochondrial disorders, mucopolysaccharidoses, Krabbe disease, Menkes disease, disorders of cobalamin (vitamin B12) transport and synthesis, ornithine aminotransferase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Ears",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hearing loss",
"       </td>",
"       <td>",
"        Peroxisomal disorders, mitochondrial disorders, lysosomal storage disorders, mucopolysaccharidoses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Mouth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gingival hyperplasia",
"       </td>",
"       <td>",
"        Oligosaccharidoses, mucopolysaccharidoses, mucolipidoses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Chest",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inverted nipples",
"       </td>",
"       <td>",
"        Congenital disorders of&nbsp;glycosylation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Abdomen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatosplenomegaly",
"       </td>",
"       <td>",
"        Lysosomal storage disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatomegaly",
"       </td>",
"       <td>",
"        Glycogen storage diseases, carnitine palmitoyltransferase II deficiency (infantile form), peroxisomal disorders, mitochondrial DNA depletion disorders, tyrosinemia type I (hepatorenal), mucolipidoses, congenital disorders of glycosylation, longer chain fatty acid oxidation disorders.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Musculoskeletal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Arthritis",
"       </td>",
"       <td>",
"        Farber disease, purine metabolism disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Neurologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dystonia",
"       </td>",
"       <td>",
"        Glutaric acidemia I, organic acidemias, Wilson disease, mitochondrial disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myopathy",
"       </td>",
"       <td>",
"        Fatty acid oxidation defects, mitochondrial disorders, Pompe disease and other glycogen storage diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Paresthesia",
"       </td>",
"       <td>",
"        Fabry disease, sialidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Peripheral neuropathy",
"       </td>",
"       <td>",
"        Congenital disorders of protein glycosylation, leukodystrophies, peroxisomal disorders, Tangier disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Psychoses",
"       </td>",
"       <td>",
"        Adult Tay-Sachs, homocystinuria, porphyrias, purine metabolism disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Skin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypopigmentation or absent pigment",
"       </td>",
"       <td>",
"        Cystinosis, Menkes disease, phenylketonuria, sialidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Angiokeratoma",
"       </td>",
"       <td>",
"        Fabry, fucosidosis, galactosialidosis, beta-mannosidosis, sialidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dermatitis",
"       </td>",
"       <td>",
"        Biotinidase deficiency, Hartnup disease, phenylketonuria, prolidase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Edema",
"       </td>",
"       <td>",
"        GM1 gangliosidosis, prolidase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hirsutism",
"       </td>",
"       <td>",
"        Oligosaccharidoses, mucopolysaccharidoses, mucolipidoses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ichthyosis",
"       </td>",
"       <td>",
"        Multiple sulfatase deficiency, isolated steroid sulfatase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Photosentization",
"       </td>",
"       <td>",
"        Porphyrias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Xanthomas",
"       </td>",
"       <td>",
"        Hyperlipoproteinemias and other disorders of lipoproteins",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Wappner RS, Hainline BE. Inborn errors of metabolism. In: Oski's Pediatrics. Principles and Practice, 3rd ed, McMillan JA, DeAngelis CD, Feigin RD, Warshaw, JB (Eds), Lippincott, Williams and Wilkins, Philadelphia, 1999. p. 1823 and Saudubray JM, Chappentier C. Clinical phenotypes: Diagnosis/algorithms. In: Metabolic and Molecular Bases of Inherited Disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill, New York, 2001. p. 1327 and Lindor NM, Karnes PS. Initial assessment of infants and children with suspected inborn errors of metabolism. Mayo Clin Proc 1995; 70:987 and Cleary MA, Green A. Developmental delay: when to suspect and how to investigate for an inborn error of metabolism. Arch Dis Child 2005; 90:1128.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11694=[""].join("\n");
var outline_f11_26_11694=null;
var title_f11_26_11695="Dx and Rx of suspected SBP";
var content_f11_26_11695=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59554&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59554&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 487px\">",
"   <div class=\"ttl\">",
"    Approach to the management of suspected spontaneous bacterial peritonitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 467px; height: 417px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_26_11695=[""].join("\n");
var outline_f11_26_11695=null;
